Publication Tracker \u2014 ASH

Comparison of aspirin and rivaroxaban for the prevention of pulmonary embolism and deep vein thrombosis in high thrombotic risk patients with systemic lupus erythematosus: study protocol for a multicentre, prospective, randomised controlled trial

Zhang et al. · Lupus science & medicine

Added to ASH registry: 2026-05-29

Dabigatran outperforms warfarin in elderly patients with atrial fibrillation and stable coronary artery disease: reduced risks of bleeding and cardiovascular events

Song et al. · American journal of translational research

Added to ASH registry: 2026-05-29

Dabigatran-induced acute hepatitis in a patient with atrial fibrillation: a rare case report

Hsu et al. · European heart journal. Case reports

Added to ASH registry: 2026-05-29

Edoxaban for stroke prevention in Chinese patients with atrial fibrillation: 1-year follow-up of the ETNA-AF-China study

Guo et al. · Frontiers in pharmacology

Added to ASH registry: 2026-05-29

Edoxaban for stroke prevention in patients with atrial fibrillation: Of randomized and real-world evidence

de · Indian pacing and electrophysiology journal

Added to ASH registry: 2026-05-29

Edoxaban-induced enterocolitis: The first case report demonstrating distinct endoscopic and histological features

Endo et al. · DEN open

Added to ASH registry: 2026-05-29

Efficacy and safety of reduced-dose versus full-dose DOACs in extended treatment of VTE: A systematic review and meta-analysis

Bilal et al. · Journal of thrombosis and thrombolysis

Added to ASH registry: 2026-05-29

Efficacy of argatroban plus alteplase versus intravenous alteplase according to diabetes mellitus in acute ischemic stroke

Hou et al. · Scientific reports

Added to ASH registry: 2026-05-29

Extended Rivaroxaban Therapy for Cancer-Associated Low-Risk Pulmonary Embolism by Chemotherapy Status: Insights from the ONCO PE Trial

Xiong et al. · Thrombosis and haemostasis

Added to ASH registry: 2026-05-29

Peak and Trough Concentration Ranges of Factor Xa Inhibitors for Preventing Thromboembolic Stroke in Korean Patients with Non-valvular Atrial Fibrillation

Park et al. · Annals of laboratory medicine

Added to ASH registry: 2026-05-29

Pharmacogenomic profiling of ABCB1 and CES1 in atrial fibrillation patients on dabigatran from a multiethnic Malaysian cohort

Tan et al. · Scientific reports

Added to ASH registry: 2026-05-29

Real-World Edoxaban Concentrations in Older Patients Receiving Reduced-Dose Regimens

Tang et al. · Clinical pharmacology and therapeutics

Added to ASH registry: 2026-05-29

Reversal of Progressive In-Hospital Posterior Artery-to-Artery Embolic Stroke With Argatroban: A Case Report

She et al. · British journal of hospital medicine (London, England : 2005)

Added to ASH registry: 2026-05-29

Total Clinical Event Burden with Edoxaban Monotherapy versus Dual Antithrombotic Therapy in Atrial Fibrillation and Stable Coronary Artery Disease: Insights from the EPIC-CAD Trial

Kim et al. · Journal of the American Heart Association

Added to ASH registry: 2026-05-29

A comprehensive multicenter study assessing the impact of abelacimab, asundexian and milvexian on coagulation assays

Goubeau et al. · Blood advances

Added to ASH registry: 2026-05-28

A heparin-functionalized scaffold loaded with pleiotrophin enhances endothelialization and angiogenic potential in liver tissue engineering

Yadav CJ et al. · Biomaterials science

Added to ASH registry: 2026-05-28

A Thorough QT Study to Assess the Effects of Milvexian on Cardiac Repolarization in Healthy Participants

Zannikos et al. · Clinical pharmacology in drug development

Added to ASH registry: 2026-05-28

Abelacimab vs Rivaroxaban in Older Individuals With Atrial Fibrillation: A Prespecified Analysis of the Phase 2b AZALEA-TIMI 71 Trial

Al et al. · JAMA cardiology

Added to ASH registry: 2026-05-28

Acute unintentional single-substance pediatric exposures to direct factor Xa inhibitors reported to US Poison Centers, 2011-2019

Kolbeck M et al. · Clinical toxicology (Philadelphia, Pa.)

Added to ASH registry: 2026-05-28

Advancing Point-of-Care Analysis: The Future of Thromboelastographic DOAC-Detection: A Systematic Review

Herpertz GU et al. · Seminars in thrombosis and hemostasis

Added to ASH registry: 2026-05-28

Andexanet alfa for the reversal of anticoagulation: Dutch practice data

Krommenhoek JF et al. · Research and practice in thrombosis and haemostasis

Added to ASH registry: 2026-05-28

Apixaban Initiation in Hemodialysis Patients With Newly Diagnosed Atrial Fibrillation

Lu et al. · American journal of kidney diseases : the official journal of the National Kidney Foundation

Added to ASH registry: 2026-05-28

Association of Edoxaban Pharmacokinetics With Bleeding in Older Patients With Atrial Fibrillation Treated With Low-Dose Edoxaban: A Post Hoc Analysis of a Randomized Controlled Trial

Okumura K et al. · Journal of the American Heart Association

Added to ASH registry: 2026-05-28

Automated Thromboelastometry for Semiquantitative Assessment of High Heparin Concentrations: A Feasibility Study in Healthy Volunteers

Pada et al. · Health science reports

Added to ASH registry: 2026-05-28

Bioinspired apixaban nanosuspension-loaded polymeric microneedle arrays for non-invasive transdermal delivery: a skin-friendly patch

Abdel-Messih HA et al. · European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V

Added to ASH registry: 2026-05-28

Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous Thromboembolism

Castellucci LA et al. · The New England journal of medicine

Added to ASH registry: 2026-05-28

Cancer-Associated Stroke Complicated by Heparin-Induced Thrombocytopenia: A case report.

Okada T et al. · Internal medicine (Tokyo, Japan)

Added to ASH registry: 2026-05-28

Caught in Transit: Mobile Right Atrial Thrombus in Intermediate-High-Risk Pulmonary Embolism Treated With Half-Dose Alteplase

Gomaa et al. · The American journal of case reports

Added to ASH registry: 2026-05-28

Combined Antithrombin and Heparin Supplementation to Blood for Restoring Heparin Responsiveness After Andexanet Alfa Exposure: An In Vitro Model

Butt et al. · EJHaem

Added to ASH registry: 2026-05-28

Comparative efficacy and safety of apixaban and rivaroxaban versus warfarin in atrial fibrillation patients with end-stage renal disease: a systematic review and meta-analysis

Wu X et al. · Renal failure

Added to ASH registry: 2026-05-28

Comparing anti-platelet and anti-thrombin therapies in the ischaemia-reperfusion injured coronary microcirculation of healthy and diabetic mice

Mitchell et al. · Basic research in cardiology

Added to ASH registry: 2026-05-28

Comparing Hemostatic Efficacy of Four-Factor Prothrombin Complex Concentrate with Andexanet Alfa in an Apixaban-Treated Polytrauma Male Porcine Model

Grottke et al. · Anesthesiology

Added to ASH registry: 2026-05-28

Delayed-type hypersensitivity to low-molecular-weight heparin and cross-reactivity to fondaparinux and danaparoid in a twin pregnancy

House et al. · Obstetric medicine

Added to ASH registry: 2026-05-28

Design and rationale of aspirin versus aspirin and fondaparinux prior to early invasive strategy in patients with NSTEMI: The FOXY trial

Fur et al. · American heart journal

Added to ASH registry: 2026-05-28

Design and rationale of the GUARD-OAC: A randomized controlled trial evaluating proton pump inhibitor cotherapy for gastrointestinal protection in patients requiring direct oral anticoagulants

Ahn HJ et al. · American heart journal

Added to ASH registry: 2026-05-28

Design, synthesis and biological evaluation of novel FXIa inhibitors featuring five-membered heterocycles as P2' fragments

Wu et al. · European journal of medicinal chemistry

Added to ASH registry: 2026-05-28

Development of an Oral Anticoagulation Strategy for Permanent Artificial Lung Support

Hong et al. · Transplantation

Added to ASH registry: 2026-05-28

Development of selective NBD-based fluorescent probes for in vitro detection of factor XIa and Thrombus imaging

Zhuang et al. · Bioorganic chemistry

Added to ASH registry: 2026-05-28

Direct Oral Anticoagulant Inhibitors: Mode of Action, Clinical Aspects

Hassan et al. · Handbook of experimental pharmacology

Added to ASH registry: 2026-05-28

Direct Oral Anticoagulants for Cancer-Associated Venous Thromboembolism in Hematologic Malignancies: A Comprehensive Review

Zhu Y et al. · European journal of haematology

Added to ASH registry: 2026-05-28

Direct Oral Anticoagulants for Portal Vein Thrombosis in Cirrhosis: From Pharmacology to Clinical Practice

Al Naamani KM et al. · Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis

Added to ASH registry: 2026-05-28

Direct Oral Anticoagulants Versus Warfarin in Atrial Fibrillation With Advanced Chronic Kidney Disease: A Systematic Review and Meta-Analysis

Metwaly AS et al. · Cureus

Added to ASH registry: 2026-05-28

Discovery of the First Highly Potent, Selective, Irreversible Small-Molecule Factor XIIa Inhibitor for Treating Sepsis

Geng et al. · Journal of medicinal chemistry

Added to ASH registry: 2026-05-28

Dose-Response Efficacy and Safety of Factor XI/XIa Inhibitors in Atrial Fibrillation; a Systematic Review and Meta-Analysis With Subgroup Exploration and Trial Sequential Validation

Faizan et al. · Clinical cardiology

Added to ASH registry: 2026-05-28

Dose-Specific Intra-Arterial Thrombolysis After Endovascular Thrombectomy for Large-Vessel Occlusion Stroke: A Network Meta-Analysis of Randomized Trials

Frechiani et al. · Stroke (Hoboken, N.J.)

Added to ASH registry: 2026-05-28

Economic evaluation of direct oral anticoagulants (DOACs) for venous thromboembolism with different etiologies: a systematic review

Karimi F et al. · Health economics review

Added to ASH registry: 2026-05-28

Efficacy and Safety of Apixaban in Cancer-Associated Thromboembolism: A Narrative Review

Aperna F et al. · Cardiology in review

Added to ASH registry: 2026-05-28

Efficacy of combined atorvastatin and argatroban therapy in acute cerebral infarction

Xu et al. · Pakistan journal of pharmaceutical sciences

Added to ASH registry: 2026-05-28

Emergency reversal of Rivaroxaban with Andexanet alfa in a child with hemorrhagic brain metastasis from Wilms tumor

Rafaelian A et al. · Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery

Added to ASH registry: 2026-05-28

Eudragit S100-coated liposomes: a pH-responsive strategy to overcome dabigatran etexilate's oral bioavailability challenge

Elsayad et al. · The Journal of pharmacy and pharmacology

Added to ASH registry: 2026-05-28

Excessive Apixaban Concentrations in a Bleeding Patient Treated With Pharmacological Reversal and Extracorporal Removal-A Case Report

Kraus RF et al. · Pharmacology research & perspectives

Added to ASH registry: 2026-05-28

Expert Opinion on Implementing Oral Anticoagulation Reversal Protocols in US Hospitals

Berger et al. · Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis

Added to ASH registry: 2026-05-28

Exploration of Mechanisms of Keliu Pill on the Inhibition of Lymphangiogenesis in Non-small Cell Lung Cancer Based on Network Pharmacology and Experimental Validation

Yang et al. · Applied biochemistry and biotechnology

Added to ASH registry: 2026-05-28

Factor XI Inhibitors in Atrial Fibrillation: Insights and Implications from Recent Trials

Falama RB et al. · Advances in therapy

Added to ASH registry: 2026-05-28

Factor XIa Inhibitors Versus Direct Oral Anticoagulants for Atrial Fibrillation: A Systematic Review and Meta-analysis of Randomized Controlled Trials

Shahid et al. · Cardiovascular drugs and therapy

Added to ASH registry: 2026-05-28

Fixed dose versus 3-day loading dose warfarin initiation in atrial fibrillation: effects on INR stabilization and time in the therapeutic range

Syed et al. · International journal of clinical pharmacy

Added to ASH registry: 2026-05-28

Fondaparinux-associated thrombocytopenia as a cause of bilateral pulmonary embolism

Acebo et al. · Medicina clinica

Added to ASH registry: 2026-05-28

From Physiology to Clinical Practice in Pancreatic Cancer-Related Thromboembolism-A Review

Jarowicz M et al. · Cancers

Added to ASH registry: 2026-05-28

Impact of Atrial Fibrillation Pattern on Edoxaban Antithrombotic Therapy in Patients With Atrial Fibrillation and Stable Coronary Artery Disease: A Secondary Analysis of the EPIC-CAD Randomized Clinical Trial

Yu et al. · Journal of the American Heart Association

Added to ASH registry: 2026-05-28

Impact of renal function on edoxaban antithrombotic therapy in patients with atrial fibrillation and stable coronary artery disease: a prespecified analysis of the EPIC-CAD trial

Lee et al. · EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology

Added to ASH registry: 2026-05-28

Increased Prophylactic Enoxaparin Dosing Is Associated With Improved Achievement of Target anti-Xa Levels; Implementation of the Western Trauma Association Venous-Thromboembolism Guidelines

McKinzie et al. · The Journal of surgical research

Added to ASH registry: 2026-05-28

Individualized antithrombotic therapy in acute coronary syndrome: The role of thrombin pathway inhibition and aspirin.

Tantry et al. · Kardiologia polska

Added to ASH registry: 2026-05-28

Interference in protein S activity testing and free protein S: impact of lupus anticoagulant, elevated factor VIII, and anticoagulants

Yan J et al. · Clinica chimica acta; international journal of clinical chemistry

Added to ASH registry: 2026-05-28

Laboratory Testing of Direct Oral Anticoagulants

Reilly-Stitt · Handbook of experimental pharmacology

Added to ASH registry: 2026-05-28

Laminin G domains define a critical interface for protein S-mediated factor IXa inhibition

Yasmin R et al. · Journal of thrombosis and haemostasis : JTH

Added to ASH registry: 2026-05-28

Markers for platelet function testing by flow cytometry: where are we now? A clinical perspective.

Spurgeon · Research and practice in thrombosis and haemostasis

Added to ASH registry: 2026-05-28

Measurement of Active Thrombin Bound to Circulating D-Dimers as a Sensitive Biomarker for Prothrombotic Conditions

Stikarova J et al. · Journal of clinical laboratory analysis

Added to ASH registry: 2026-05-28

Mechanistic prediction of apixaban and rivaroxaban secretion into human milk and infant systemic exposure through an integrated physiologically based pharmacokinetic framework

Yi B et al. · Drug metabolism and disposition: the biological fate of chemicals

Added to ASH registry: 2026-05-28

Naringin binds and activates protein C inhibitor for enhanced inhibition of thrombin and activated protein C with implications in coagulation control

Siddiqui U et al. · Journal of biomolecular structure & dynamics

Added to ASH registry: 2026-05-28

Non-ST-segment elevation acute coronary syndrome: understanding the full spectrum to guide management.

Savonitto et al. · European heart journal

Added to ASH registry: 2026-05-28

Off-label underdosing of edoxaban antithrombotic therapy for patients with atrial fibrillation and stable coronary artery disease: findings from the EPIC-CAD trial

Cho et al. · Heart (British Cardiac Society)

Added to ASH registry: 2026-05-28

Optimising protamine dosing for heparin reversal after cardiopulmonary bypass: a population pharmacokinetic-pharmacodynamic study

Lanoiselée et al. · British journal of anaesthesia

Added to ASH registry: 2026-05-28

Perioperative Management of Immune Thrombocytopenic Purpura in Cardiac Surgery: A Systematic Review of the Literature in Urgent and Elective Settings

Said K et al. · Cureus

Added to ASH registry: 2026-05-28

Perioperative Transfusion Requirements in Pediatric Patients Receiving Apixaban Prior to Cardiac Surgery With Cardiopulmonary Bypass

Longacre et al. · Journal of cardiothoracic and vascular anesthesia

Added to ASH registry: 2026-05-28

Pharmacologic Factor XI/XIa Inhibitors: What the Laboratory Hematologist Needs to Know

Weitz et al. · Clinics in laboratory medicine

Added to ASH registry: 2026-05-28

PK/PD interactions of antiarrhythmic drugs and oral anticoagulants in atrial fibrillation patients: clinical implications for stroke and dementia prevention

Oh et al. · Toxicological research

Added to ASH registry: 2026-05-28

Postoperative reduction in thrombin generation induced by elevated levels of tissue factor pathway inhibitor in cardiac surgery: a prospective observational study

Kitajo et al. · Journal of anesthesia

Added to ASH registry: 2026-05-28

Prevalence of Potentially Inappropriate Apixaban Prescribing Within a Single-Centre Tertiary Hospital

Creeper et al. · Australasian journal on ageing

Added to ASH registry: 2026-05-28

Prothrombin complex concentrate for reversal of factor Xa inhibitor-associated acute major gastrointestinal bleeding

Shamiea M et al. · The American journal of medicine

Added to ASH registry: 2026-05-28

Quality Assurance in Platelet Function Testing.

Smock et al. · Clinics in laboratory medicine

Added to ASH registry: 2026-05-28

Quantitative Model-Informed Dose Selection for a Milvexian Phase III Study in Patients With Atrial Fibrillation

Zhou et al. · Clinical pharmacology and therapeutics

Added to ASH registry: 2026-05-28

Randomized trial of low-dose, ultrasound-assisted thrombolysis or heparin for pulmonary embolism.

Kjaergaard J et al. · Cardiovascular research

Added to ASH registry: 2026-05-28

Rational design of heparin antagonist: Guanidine-based mimetics unveil key carbohydrate-carbohydrate interactions

Chandra et al. · European journal of medicinal chemistry

Added to ASH registry: 2026-05-28

Rationale for the milvexian dosing in the phase 3 LIBREXIA program

Weitz et al. · Journal of thrombosis and haemostasis : JTH

Added to ASH registry: 2026-05-28

Real-Time Individualization of UFH Dosing in Cardiac Procedures: Development and Validation of an Online ACT-Based Target-Controlled Tool

Ollier et al. · Journal of cardiothoracic and vascular anesthesia

Added to ASH registry: 2026-05-28

Recent advances in factor XII(a) inhibitors: an updated patent landscape (2020-present)

Kalinin et al. · Expert opinion on therapeutic patents

Added to ASH registry: 2026-05-28

Relevance and limitations of clinical follow-up in a pharmacokinetic study on direct oral anticoagulants

Terrier et al. · Frontiers in pharmacology

Added to ASH registry: 2026-05-28

Reperfusion thrombolytic therapy for ischemic stroke in patients on non-vitamin K antagonist oral anticoagulants: study protocol of a phase II randomized clinical trial

Karaszewski B et al. · Trials

Added to ASH registry: 2026-05-28

Retrospective modeling study of ChatGPT (GPT 4) warfarin dose adjustment in patients with INRs outside the therapeutic range

Tezcan et al. · Digital health

Added to ASH registry: 2026-05-28

Reusing Blood Samples from a Hospital-based Cohort to Apixaban Plasma Concentrations

Murray et al. · medRxiv : the preprint server for health sciences

Added to ASH registry: 2026-05-28

Role of Concentration in Opposing Effects of Anandamide on Nociceptive Synapses versus Non-nociceptive Synapses

Burrell BD · eNeuro

Added to ASH registry: 2026-05-28

Safety and efficacy of direct oral anticoagulants in pediatric oncology patients: real-world data from two quaternary care pediatric centers

Kumar R et al. · Research and practice in thrombosis and haemostasis

Added to ASH registry: 2026-05-28

Safety of Prothrombin Complex Concentrate for Emergency Surgery According to the Oral Factor Xa Inhibitor Level

Eshaghpour A et al. · Thrombosis and haemostasis

Added to ASH registry: 2026-05-28

Simplifying the next-generation of anticoagulants: Elexians - Why a unified nomenclature for FXI/XIa inhibitors is needed

Kholmukhamedov et al. · Thrombosis research

Added to ASH registry: 2026-05-28

Single-domain antibodies to reverse the effects of factor Xa inhibitors on coagulation tests

Zhao J et al. · Journal of thrombosis and haemostasis : JTH

Added to ASH registry: 2026-05-28

Systematic review on the design and methodology of the pediatric direct oral anticoagulant clinical trials for thrombosis prevention: communication from the ISTH SSC Subcommittee on Pediatric and Neonatal Thrombosis and Hemostasis

Whitworth H et al. · Journal of thrombosis and haemostasis : JTH

Added to ASH registry: 2026-05-28

Targeting Factor XI for Safer Anticoagulation: Emerging Data and Future Directions

Campanella F et al. · American journal of cardiovascular drugs : drugs, devices, and other interventions

Added to ASH registry: 2026-05-28

The Advances in Novel Delivery Strategies for Hirudin Against Cardiovascular Diseases

Li M et al. · Pharmaceuticals (Basel, Switzerland)

Added to ASH registry: 2026-05-28

The impact of body composition variability on coagulation monitoring in patients on direct oral factor Xa inhibitors for treatment of venous thromboembolism

Kurzmann-Guetl et al. · Frontiers in cardiovascular medicine

Added to ASH registry: 2026-05-28

The in vitro anticoagulant effect of milvexian in healthy neonates and children

Letunica et al. · Thrombosis research

Added to ASH registry: 2026-05-28

The ocular surface in type 2 diabetes: pathophysiology and impact of anti-diabetic drugs

Singh et al. · Progress in retinal and eye research

Added to ASH registry: 2026-05-28

The Risk for Bleeding in Patients With Atrial Fibrillation From Concomitant Use of Apixaban or Rivaroxaban With Diltiazem Compared With Metoprolol

Dawwas GK et al. · Annals of internal medicine

Added to ASH registry: 2026-05-28

Thrombosis Across Female-Specific Malignancies: From Chemotherapy-Driven Risk to Prophylaxis and Drug Interactions

Aghakouchakzadeh M et al. · Pharmacotherapy

Added to ASH registry: 2026-05-28

Trends in Antithrombotic Therapy Initiation Among Patients With Stroke Pre- and Post-COVID-19 in Sweden-An Interrupted Time Series Study

Mousa et al. · Basic & clinical pharmacology & toxicology

Added to ASH registry: 2026-05-28

Use of Apixaban for Venous Thromboembolism Prophylaxis in an Older Hemodialysis Patient After Total Knee Replacement: A Case Report

Alanizi AH et al. · The American journal of case reports

Added to ASH registry: 2026-05-28

Venous thromboembolism prevention and treatment with factor XI/XIa inhibitors: current status and future perspectives

Del et al. · Journal of thrombosis and thrombolysis

Added to ASH registry: 2026-05-28

Venous thromboembolism prophylaxis in the intensive care unit: Is there a future role for factor XI/XIa inhibitors as novel antithrombotic agents?

Porres-Aguilar et al. · Medicina intensiva

Added to ASH registry: 2026-05-28

Weight based dosing of prophylactic enoxaparin was not associated with reduced venous thromboembolism events following open reduction and internal fixation of acetabular fractures

Nian et al. · European journal of orthopaedic surgery & traumatology : orthopedie traumatologie

Added to ASH registry: 2026-05-28

A network pharmacology-based study on the mechanism of hirudin attenuates renal interstitial fibrosis through Nrf2 and NF-κB signalling pathways

Yang K et al. · Naunyn-Schmiedeberg's archives of pharmacology

Added to ASH registry: 2026-05-27

Alternate and Emerging Anticoagulation Strategies for Extracorporeal Membrane Oxygenation: A Scoping Review

Kumar A et al. · Journal of Clinical Medicine

Added to ASH registry: 2026-05-27

Alternate and Emerging Anticoagulation Strategies for Extracorporeal Membrane Oxygenation: A Scoping Review

Kumar AP et al. · Journal of clinical medicine

Added to ASH registry: 2026-05-27

Alternative anticoagulants in heparin-sensitive patients undergoing carotid artery interventions: A scoping review

Dmitriev AP et al. · Journal of vascular surgery

Added to ASH registry: 2026-05-27

An Overview of Anticoagulant Drugs Pharmacology, Therapeutic Approaches, Limitations and Perspectives

Morgovan C et al. · Pharmaceutics

Added to ASH registry: 2026-05-27

Anticoagulant peptide LR from Whitmania pigra ameliorates cerebral ischemia-reperfusion injury

Liu R et al. · Brain research

Added to ASH registry: 2026-05-27

Anticoagulant peptide LR from Whitmania pigra ameliorates cerebral ischemia-reperfusion injury

Liu R et al. · Brain Research

Added to ASH registry: 2026-05-27

Anticoagulation management and monitoring in ECMO: an international survey from the ISTH SSC Subcommittee on Pediatric and Neonatal Thrombosis and Hemostasis

Regling K et al. · Research and Practice in Thrombosis and Haemostasis

Added to ASH registry: 2026-05-27

Argatroban Anticoagulation for Heparin Induced Thrombocytopenia After Heartmate 3 Implantation: A Case Series

Palacios-Castello C et al. · Transplantation Proceedings

Added to ASH registry: 2026-05-27

Commensal-myeloid crosstalk in neonatal skin regulates interleukin-1 signaling and cutaneous type 17 inflammation

Dhariwala MO et al. · Immunity

Added to ASH registry: 2026-05-27

Construction of Corynebacterium glutamicum for efficient secretion and production of recombinant proteins using the technology of ARTP mutagenesis and fluorescen activated droplet microfluidic screening

Liu X et al. · Bioresource technology

Added to ASH registry: 2026-05-27

Current use and limitations of direct thrombin inhibitors in pediatric ECMO: A European survey

Gardeton P et al. · Perfusion

Added to ASH registry: 2026-05-27

Current use and limitations of direct thrombin inhibitors in pediatric ECMO: A European survey

Gardeton T et al. · Perfusion

Added to ASH registry: 2026-05-27

Delayed-onset, persisting autoimmune heparin-induced thrombocytopenia with thrombosis following craniofacial surgery

Will VJ et al. · BMJ Case Reports

Added to ASH registry: 2026-05-27

Dilute Thrombin Time to Monitor Bivalirudin in Pediatric Extracorporeal Membrane Oxygenation — Progress Does Not Always Have to Cost More

Niebler RA · Pediatric Critical Care Medicine

Added to ASH registry: 2026-05-27

Duplication of the Antistasin-Like Structure Resulted in a New Anticoagulant Protein in the Medicinal Leech

Brovina KA et al. · Biomolecules

Added to ASH registry: 2026-05-27

Elucidating the neuroinflammatory modulatory mechanisms of Maixuekang capsule via network pharmacology and proteomics

Han et al. · Developmental neurobiology

Added to ASH registry: 2026-05-27

Elucidating the Neuroinflammatory Modulatory Mechanisms of Maixuekang Capsule via Network Pharmacology in Cerebral Ischemia/Reperfusion Injury Rats

Han H et al. · Developmental Neurobiology

Added to ASH registry: 2026-05-27

Evaluation of bivalirudin-based anticoagulation for extracorporeal membrane oxygenation, including patients with COVID-19

Raguindin M et al. · The journal of extra-corporeal technology

Added to ASH registry: 2026-05-27

Gene Expression Underlying Teloblast Formation in Leech (Annelida: Hirudinae)

Hsiao S et al. · Evolutionary bioinformatics online

Added to ASH registry: 2026-05-27

Genetically Encoded Multivalent Elastin-Like Polypeptide-Haemadin Fusion Proteins for Prolonged Antithrombotic Protection

Yang H et al. · Biomacromolecules

Added to ASH registry: 2026-05-27

Heparin-induced Thrombocytopenia During Multiple Extracorporeal Mechanical Support for Fulminant Myocarditis: A Case Report with a Literature Review

Morita Y et al. · Internal Medicine (Tokyo)

Added to ASH registry: 2026-05-27

Hirudin ameliorates kidney injury in DKD mice by decreasing SOD2 β-hydroxybutyrylation mediated ROS level and NLRP3 inflammasome formation

Li Y et al. · FASEB journal

Added to ASH registry: 2026-05-27

Identification and characterization of WpDestabilase, a novel destabilase from the salivary glands of Whitmania pigra

Huang B et al. · Protein expression and purification

Added to ASH registry: 2026-05-27

Impact of heparin-to-bivalirudin bridging time on hospitalization and safety outcomes in PCI for acute coronary syndrome

Wang G et al. · Frontiers in cardiovascular medicine

Added to ASH registry: 2026-05-27

Molecular Insights into Leech-Derived Bioactive Compounds: Biochemical Mechanisms and Therapeutic Potential

Raghavi S et al. · International journal of molecular sciences

Added to ASH registry: 2026-05-27

Multicenter Registry Analysis of Bivalirudin for Primary Anticoagulation in Pediatric HeartMate 3 Recipients: ACTION Analysis

Lynch A et al. · ASAIO Journal

Added to ASH registry: 2026-05-27

Nitric oxide in the ECMO circuit as a treatment option for heparin-induced thrombocytopenia: A case report

Joelsons D et al. · Perfusion

Added to ASH registry: 2026-05-27

Postprocedural anticoagulation after primary percutaneous coronary intervention: 1-year results

Yan et al. · JACC. Asia

Added to ASH registry: 2026-05-27

Recombinant Fusion Protein Composed of Hirudin and Annexin A5 Shows Anti-Coagulant Activity In Vitro

Dong H et al. · Applied biochemistry and biotechnology

Added to ASH registry: 2026-05-27

Resolving Bivalirudin Interference on Fibrinogen Testing by the Use of Activated Carbon

Du J et al. · Journal of clinical laboratory analysis

Added to ASH registry: 2026-05-27

The great diversity: monomeric and oligomeric hirudins, hirudin-like factors and decorsins in the Asian medicinal leeches Hirudo nipponia and Hirudo tianjinensis

Kalatehjari P et al. · Parasitology research

Added to ASH registry: 2026-05-27

Thromboembolism related to heparin-induced thrombocytopenia during Impella support after cardiac surgery for free wall rupture: a case report

Aratame A et al. · AME Case Reports

Added to ASH registry: 2026-05-27

Traditional Chinese medicine in the treatment of diabetic kidney disease: the mechanisms of signaling pathways regulations

Li W et al. · Frontiers in endocrinology

Added to ASH registry: 2026-05-27

Updates on Use and Monitoring of Direct Thrombin Inhibitors

Navaei A et al. · Clinics in laboratory medicine

Added to ASH registry: 2026-05-27

Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT)-like Syndrome: A Case Report and Some Considerations on a Novel Diagnostic and Therapeutic Challenge

Delfino L et al. · Diagnostics

Added to ASH registry: 2026-05-27

Molecular Insights into Leech-Derived Bioactive Compounds: Biochemical Mechanisms and Therapeutic Potential

Raghavi S, Deva Darshini B, Saravanan KM, Anbarasu K · International journal of molecular sciences

Added to ASH registry: 2026-05-26

Effects of hirudotherapy on liver functions, lipid profile, and insulin sensitivity in rats with metabolic syndrome

Bilden A et al. · BMC complementary medicine and therapies

Added to ASH registry: 2026-03-18

A Cost-Effectiveness Analysis of Rivaroxaban Compared to Warfarin for the Management of Venous Thromboembolism in Western Kenya

O'Neill et al. · Clinical drug investigation

Added to ASH registry: 2026-05-29

Administration of decapsulated dabigatran via nasogastric tube: A case report

Kaneta et al. · American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists

Added to ASH registry: 2026-05-29

Analysis of hemorrhagic transformation and intracerebral hemorrhage under combination therapy with alteplase and antiplatelets or anticoagulants, using the Japanese Adverse Drug Event Report database

Nakai et al. · PloS one

Added to ASH registry: 2026-05-29

Argatroban plus alteplase in posterior versus anterior circulation stroke

Cui et al. · Annals of clinical and translational neurology

Added to ASH registry: 2026-05-29

Argatroban plus dual antiplatelet therapy versus dual antiplatelet alone for acute atherothrombotic cerebral infarction

Nakashima et al. · International journal of stroke : official journal of the International Stroke Society

Added to ASH registry: 2026-05-29

Association Between Argatroban and Outcomes of Branch Atheromatous Disease: A Propensity-Matched Analysis From MRI-Based Study

Li et al. · CNS neuroscience & therapeutics

Added to ASH registry: 2026-05-29

Association of Genetic Variants With Rivaroxaban Pharmacokinetics and Pharmacodynamics and Hemorrhage Risk Factors in Patients With Venous Thromboembolism

Li et al. · Journal of the American Heart Association

Added to ASH registry: 2026-05-29

Biological Variation of Hemostasis Analytes in Atrial Fibrillation Patients Using Dabigatran

Tilly et al. · The journal of applied laboratory medicine

Added to ASH registry: 2026-05-29

Bleeding risk among cancer patients receiving concurrent CYP-interacting tyrosine kinase inhibitors with direct oral anticoagulants versus alternative anticoagulation therapies

Tan et al. · Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Added to ASH registry: 2026-05-29

Bleeding Risk in the Early Postoperative Period after Atrial Fibrillation Ablation with Anticoagulant Therapy Using Dabigatran Etexilate

Takashima et al. · Biological & pharmaceutical bulletin

Added to ASH registry: 2026-05-29

Cost-effectiveness of apixaban in non-valvular atrial fibrillation (NVAF) based on effectiveness data from a Spanish study in clinical practice (real-world evidence)

Anguita et al. · Expert review of cardiovascular therapy

Added to ASH registry: 2026-05-29

Dabigatran Attenuates the Binding of Thrombin to Platelets-A Novel Mechanism of Action

Lindahl et al. · Thrombosis and haemostasis

Added to ASH registry: 2026-05-29

Does direct oral anticoagulant lead-in dosing following initial parenteral therapy affect clinical outcomes in acute venous thromboembolism?: A retrospective cohort study

Kim et al. · International journal of clinical pharmacy

Added to ASH registry: 2026-05-29

Drug-drug interactions between epidermal growth factor receptor tyrosine kinase inhibitors and rivaroxaban in vitro and in vivo

Wang et al. · PloS one

Added to ASH registry: 2026-05-29

Edoxaban Monotherapy and Incidence of Transcatheter Heart Valve Leaflet Thrombosis - The Rotterdam Edoxaban (REDOX) Study

Adrichem et al. · Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions

Added to ASH registry: 2026-05-29

Effect of Argatroban Plus Dual Antiplatelet in Branch Atherosclerosis Disease: A Randomized Clinical Trial

Xu et al. · Stroke

Added to ASH registry: 2026-05-29

Effectiveness and Safety of Dose-Specific DOACs in Patients With Atrial Fibrillation: A Systematic Review and Network Meta-Analysis

Oh et al. · Cardiovascular therapeutics

Added to ASH registry: 2026-05-29

Effectiveness and Safety of Edoxaban in the Routine Clinical Care of Atrial Fibrillation Patients in Brazil: Prospective 1-Year Follow-Up Study - EdoBRA

Precoma et al. · Arquivos brasileiros de cardiologia

Added to ASH registry: 2026-05-29

Effectiveness and safety of rivaroxaban in patients with atrial fibrillation and heart failure in clinical practice: an indirect comparison of national and international registries

Cepeda et al. · Frontiers in cardiovascular medicine

Added to ASH registry: 2026-05-29

Effects of Argatroban on Hcy, hs-CRP and FIB levels in patients with acute cerebral infarction

Yang et al. · The International journal of neuroscience

Added to ASH registry: 2026-05-29

Efficacy and safety of reduced-dose versus full-dose direct oral anticoagulants for extended treatment of venous thromboembolism: A meta-analysis with trial sequential analysis and reconstructed time-to-event data

Ibrahim et al. · Thrombosis research

Added to ASH registry: 2026-05-29

Efficacy of antiplatelet drugs combined with Argatroban in treating acute ischemic stroke and its impact on patients' coagulation function and neurological function: a preliminary trial

Sun et al. · The International journal of neuroscience

Added to ASH registry: 2026-05-29

Evaluation of extended direct oral anticoagulant dosing strategies in patients with and without cancer from a prospective observational registry

Vlazny et al. · Research and practice in thrombosis and haemostasis

Added to ASH registry: 2026-05-29

Impact of Factor Xa inhibitors on cardiovascular events in older patients with nonvalvular atrial fibrillation

Takahashi et al. · Aging

Added to ASH registry: 2026-05-29

Impact of weight/BMI on clinical and bleeding events in 26 805 atrial fibrillation patients on edoxaban from the Global ETNA-AF Registry

Boriani et al. · European journal of preventive cardiology

Added to ASH registry: 2026-05-29

In vivo Pharmacokinetic Interactions Between Palbociclib and Rivaroxaban or Apixaban: Implications for Increased Drug Exposure and Dose Adjustments

Du et al. · Drug design, development and therapy

Added to ASH registry: 2026-05-29

In Vivo pharmacokinetic interactions of ribociclib with rivaroxaban and apixaban in rats: implications for increased drug exposure and dose adjustments

Liu et al. · Frontiers in pharmacology

Added to ASH registry: 2026-05-29

Laboratory Measurement of Rivaroxaban in Patient with Cancer-Associated Thromboembolism; Focus on Initial Rivaroxaban Therapy

Yoon et al. · Clinical laboratory

Added to ASH registry: 2026-05-29

Literature-based case analysis of serious adverse drug events associated with edoxaban

Luan et al. · European journal of clinical pharmacology

Added to ASH registry: 2026-05-29

Low-dose direct oral anticoagulants for secondary prevention in patients at high risk for recurrence due to history of recurrent venous thromboembolic events or severe thrombophilia: a retrospective analysis of the Italian Survey on anTicoagulated pAtients RegisTry 2

Poli et al. · Journal of thrombosis and haemostasis : JTH

Added to ASH registry: 2026-05-29

Outcomes of Different Regimens of Rivaroxaban and Aspirin in Cardiovascular Diseases: A Network Meta-Analysis

Al-Salihi et al. · Journal of clinical medicine

Added to ASH registry: 2026-05-29

Plasma Concentrations of Direct Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation and Different Degrees of Obesity

Menichelli et al. · Clinical pharmacokinetics

Added to ASH registry: 2026-05-29

Population pharmacokinetics of edoxaban in geriatric patients with atrial fibrillation

Edwina et al. · Journal of thrombosis and haemostasis : JTH

Added to ASH registry: 2026-05-29

Rivaroxaban for Venous Thromboembolism (VTE) in Paediatric Patients: An institutional retrospective observational study from the Low/Middle Income setting in Pakistan

Mahmood et al. · JPMA. The Journal of the Pakistan Medical Association

Added to ASH registry: 2026-05-29

Rivaroxaban Treatment in Pediatric Patients With Hematologic Malignancies and Venous Thromboembolism: A Report of Four Cases

Fukunaga et al. · Cureus

Added to ASH registry: 2026-05-29

Rivaroxaban versus low-molecular-weight heparins for short- and long-term prognosis in patients with deep vein thrombosis after spontaneous intracranial hemorrhage

Li et al. · Journal of comparative effectiveness research

Added to ASH registry: 2026-05-29

Rivaroxaban vs. enoxaparin for preventing venous thromboembolism after hip fracture operations: a retrospective cohort study

Zheng et al. · Frontiers in surgery

Added to ASH registry: 2026-05-29

Safety and efficacy of argatroban combined with antiplatelet therapy for acute mild-to-moderate ischemic stroke with large artery atherosclerosis

Yan et al. · Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association

Added to ASH registry: 2026-05-29

Screening thrombin inhibitors from Yangxinshi tablets by online capillary electrophoresis-based immobilized enzyme microreactor and molecular docking

Liu et al. · Phytochemical analysis : PCA

Added to ASH registry: 2026-05-29

Site-Specific Antithrombotic Therapy: 24-Month Outcomes of the Randomized DESyne BDS Plus Trial Using a Novel Triple-Drug Eluting Coronary Implant With Two Anticoagulants and Sirolimus

Verheye et al. · Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions

Added to ASH registry: 2026-05-29

Three Year Follow-Up of Reduced Dose of Direct Oral Anticoagulants for Extended Treatment of Venous Thromboembolism: An Ambispective Cohort Study

Valeriani et al. · Diagnostics (Basel, Switzerland)

Added to ASH registry: 2026-05-29

Timely Initiation of Argatroban Improves Prognosis in Patients With Acute Ischemic Stroke Attributed to Large Artery Atherosclerosis: A Cohort Study

Liu et al. · Brain and behavior

Added to ASH registry: 2026-05-29

Treatment of portal vein thrombosis with rivaroxaban in an American cocker spaniel with chronic hepatitis: a case report

Niijima et al. · The Journal of veterinary medical science

Added to ASH registry: 2026-05-29

Two-year clinical outcomes of Taiwanese and other Asian ethnicities with atrial fibrillation treated with edoxaban in the ETNA-AF Asia registry

Wang et al. · Journal of arrhythmia

Added to ASH registry: 2026-05-29

Two-Year Follow-Up of Patients With Atrial Fibrillation Receiving Edoxaban in Routine Clinical Practice: Results From the Global ETNA-AF Program

De et al. · Clinical cardiology

Added to ASH registry: 2026-05-29

US cost-effectiveness analysis of apixaban compared with warfarin, dabigatran and rivaroxaban for nonvalvular atrial fibrillation, focusing on equal value of life years and health years in total

Atreja et al. · Journal of comparative effectiveness research

Added to ASH registry: 2026-05-29

Usual On-therapy Ranges of Drug Concentrations in Patients with Atrial Fibrillation Treated with Direct Oral Anticoagulants: A Systematic Review and Meta-analysis

de et al. · Thrombosis and haemostasis

Added to ASH registry: 2026-05-29

Variability of Argatroban Effects on the Multiple APTT Reagents in High and Low Coagulation Activity Samples

Kumano et al. · International journal of laboratory hematology

Added to ASH registry: 2026-05-29

2025 ESVM Guidelines on interventional treatment of venous thromboembolism.

Schlager O et al. · VASA. Zeitschrift fur Gefasskrankheiten

Added to ASH registry: 2026-05-28

A novel bacteriophage pAEh1 for controlling Aeromonas hydrophila infection in aquaculture.

Jiang S et al. · Fish & shellfish immunology

Added to ASH registry: 2026-05-28

A Phase 1 Study to Assess the Effect of Fruquintinib on the Pharmacokinetics of P-gp and BCRP Substrates in Healthy Subjects

Gonzalez et al. · Clinical and translational science

Added to ASH registry: 2026-05-28

A Single-Domain VNAR Nanobody Binds with High-Affinity and Selectivity to the Heparin Pentasaccharide Fondaparinux

Gschwandtner et al. · International journal of molecular sciences

Added to ASH registry: 2026-05-28

A UK-wide analysis of 2265 patients receiving a reversal agent for direct oral anticoagulant-associated bleeding.

? et al. · Journal of thrombosis and haemostasis : JTH

Added to ASH registry: 2026-05-28

Abelacimab Has Fewer Bleeds Than Rivaroxaban, But Study Has Several Important Biases

Ebell. · American family physician

Added to ASH registry: 2026-05-28

Abelacimab versus Rivaroxaban in Patients with Atrial Fibrillation

Ruff et al. · The New England journal of medicine

Added to ASH registry: 2026-05-28

Abelacimab versus Rivaroxaban in Patients with Atrial Fibrillation

Henry. · The New England journal of medicine

Added to ASH registry: 2026-05-28

Abelacimab versus Rivaroxaban in Patients with Atrial Fibrillation

Raschi et al. · The New England journal of medicine

Added to ASH registry: 2026-05-28

Abelacimab Versus Rivaroxaban in Patients With Atrial Fibrillation on Antiplatelet Therapy: A Prespecified Analysis of the AZALEA-TIMI 71 Trial

Al et al. · Circulation

Added to ASH registry: 2026-05-28

Abelacimab Versus Rivaroxaban in Patients With Atrial Fibrillation Receiving Oral Antiplatelet Therapy: Definitely Safe, but How Effective?

Steg et al. · Circulation

Added to ASH registry: 2026-05-28

Abelacimab versus rivaroxaban in patients with atrial fibrillation: Insights into the AZALEA-TIMI 71 study

Kattamuri et al. · Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion

Added to ASH registry: 2026-05-28

Abelacimab versus Rivaroxaban in Patients with Atrial Fibrillation. Reply

Ruff et al. · The New England journal of medicine

Added to ASH registry: 2026-05-28

Alternative Anticoagulation for Patients with Heparin-Induced Thrombocytopenia on ECMO: A Narrative Review

Unic-Stojanovic D et al. · Biomedicines

Added to ASH registry: 2026-05-28

American Society of Hematology/International Society on Thrombosis and Haemostasis 2024 updated guidelines for treatment of venous thromboembolism in pediatric patients.

Monagle et al. · Blood advances

Added to ASH registry: 2026-05-28

An External Control Arm for the Oral Factor XIa Inhibitor Asundexian Phase 2 Trial in Atrial Fibrillation (PACIFIC-AF) Using Electronic Health Records

Vaitsiakhovich et al. · Cardiology and therapy

Added to ASH registry: 2026-05-28

Andexanet Alfa in Emergency Cranial Neurosurgical Procedures: A Bicentric Analysis of Efficacy and Safety

Hounchonou HF et al. · Neurocritical care

Added to ASH registry: 2026-05-28

Andexanet Alfa in Urgent Cardiac Surgery: A Case Report of Edoxaban Reversal for Acute Hemopericardium.

Al Mawed M et al. · The American journal of case reports

Added to ASH registry: 2026-05-28

Andexanet alfa-induced heparin resistance during percutaneous coronary intervention for ST-elevation myocardial infarction: a case report

Sasaki S et al. · European heart journal. Case reports

Added to ASH registry: 2026-05-28

Anticoagulant and anti-inflammatory effects of fondaparinux sodium during anterior cruciate ligament reconstruction in high risk VTE patients: A randomised controlled, triple blinded, prospective study

Zheng et al. · Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA

Added to ASH registry: 2026-05-28

Anticoagulant drugs targeting factor XI/XIa and coagulation tests: we urgently need reliable pharmacodynamic data

Gouin-Thibault et al. · Journal of thrombosis and haemostasis : JTH

Added to ASH registry: 2026-05-28

Anticoagulation during Extracorporeal Membrane Oxygenation (ECMO): A Selective Inhibitor of Activated Factor XII Compared to Heparin in an Ex Vivo Model

Gandini et al. · ACS pharmacology & translational science

Added to ASH registry: 2026-05-28

Anticoagulation in Atrial Fibrillation: Is a Paradigm Shift From Xa to XIa Inhibitors on the Horizon?

Zaman. · Cardiology in review

Added to ASH registry: 2026-05-28

Anticoagulation management and poor clinical outcomes in tamariki and rangatahi with rheumatic heart disease following mechanical valve replacement surgery in Counties Manukau.

Tangirala et al. · The New Zealand medical journal

Added to ASH registry: 2026-05-28

Anticoagulation Management During ECMO: Narrative Review.

Vajter et al. · JHLT open

Added to ASH registry: 2026-05-28

Antiplatelet-anticoagulant, APAC, a mimic of endogenous heparin, is an antithrombotic with von Willebrand factor-mediated characteristics

Jouppila et al. · Thrombosis research

Added to ASH registry: 2026-05-28

Antithrombotic Therapy in Acute Coronary Syndrome Patients with End-Stage Renal Disease: Navigating Efficacy and Safety.

Abdeldayem et al. · Journal of clinical medicine

Added to ASH registry: 2026-05-28

Apixaban and Recurrent Stroke Risk With Left Ventricular Dysfunction: A Secondary Analysis of the ARCADIA Trial

Sharma et al. · Stroke

Added to ASH registry: 2026-05-28

Apixaban for Extended Treatment of Provoked Venous Thromboembolism

Piazza et al. · The New England journal of medicine

Added to ASH registry: 2026-05-28

Apixaban Versus Enoxaparin for Venous Thromboembolism Prophylaxis in Colorectal Surgery

Ziegler et al. · The Journal of surgical research

Added to ASH registry: 2026-05-28

Apixaban versus warfarin for treatment of venous thromboembolism in patients with severe renal impairment: a multicenter study

Hanke et al. · Journal of thrombosis and thrombolysis

Added to ASH registry: 2026-05-28

Argatroban for intraoperative anticoagulation in a patient with history of heparin-induced thrombocytopenia and end-stage renal disease undergoing left atrial appendage occlusion: a case report

Eappen K et al. · Frontiers in medicine

Added to ASH registry: 2026-05-28

Argatroban-Associated Adverse Events: An Analysis Based on FDA Adverse Event Reporting System (FAERS)

Ren et al. · Cardiovascular toxicology

Added to ASH registry: 2026-05-28

Association between the Use of Fondaparinux Plus Radial Access and Clinical Outcomes in Patients with Non-ST Elevation Acute Coronary Syndrome

Ritt et al. · Arquivos brasileiros de cardiologia

Added to ASH registry: 2026-05-28

Asundexian or Apixaban in Patients With Atrial Fibrillation According to Prior Oral Anticoagulant Use: A Subgroup Analysis of the OCEANIC-AF Randomized Clinical Trial

Alexander et al. · JAMA cardiology

Added to ASH registry: 2026-05-28

Asundexian versus Apixaban in Patients with Atrial Fibrillation

Straw et al. · The New England journal of medicine

Added to ASH registry: 2026-05-28

Asundexian versus Apixaban in Patients with Atrial Fibrillation

Benkhoff et al. · The New England journal of medicine

Added to ASH registry: 2026-05-28

Asundexian versus Apixaban in Patients with Atrial Fibrillation

Piccini et al. · The New England journal of medicine

Added to ASH registry: 2026-05-28

Asundexian versus Apixaban in Patients with Atrial Fibrillation. Reply

Piccini et al. · The New England journal of medicine

Added to ASH registry: 2026-05-28

Asundexian: A Friend or a Foe for Atrial Fibrillation?

Danish et al. · Clinical Medicine Insights. Cardiology

Added to ASH registry: 2026-05-28

Asundexian: a systematic review of safety, efficacy, and pharmacological insights in thrombosis

Aldeen et al. · Thrombosis journal

Added to ASH registry: 2026-05-28

AZALEA-TIMI 71 trial: less bleeding with abelacimab compared to rivaroxaban in atrial fibrillation, but stroke prevention is uncertain

Gragnano et al. · European heart journal. Cardiovascular pharmacotherapy

Added to ASH registry: 2026-05-28

Balancing Safety and Efficacy: Factor XIa INHIBITORS vs. DOACs in Patients with Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Khater et al. · Journal of clinical medicine

Added to ASH registry: 2026-05-28

Basics of diagnosis and treatment of venous thromboembolism.

Cox et al. · Journal of thrombosis and haemostasis : JTH

Added to ASH registry: 2026-05-28

Biomarkers of sepsis-induced coagulopathy: diagnostic insights and potential therapeutic implications.

Curtiaud et al. · Annals of intensive care

Added to ASH registry: 2026-05-28

Bivalirudin functionalized hydrogel coating capable of catalytical NO-generation for enhanced anticorrosion and biocompatibility of magnesium alloy

Pan et al. · Materials today. Bio

Added to ASH registry: 2026-05-28

Catheter-based left atrial appendage CLOSURE in patients with atrial fibrillation at high risk of stroke and bleeding as compared to best medical therapy: Rationale and design of the prospective randomized CLOSURE-AF trial.

Landmesser et al. · American heart journal

Added to ASH registry: 2026-05-28

Certolizumab pegol to prevent adverse pregnancy outcomes in patients with antiphospholipid syndrome and lupus anticoagulant (IMPACT): results of a prospective, single-arm, open-label, phase 2 trial.

Branch et al. · Annals of the rheumatic diseases

Added to ASH registry: 2026-05-28

Chemical composition analysis of the proteins of leech extract with anti-pulmonary fibrosis and their effects on metabolomics based on chromatography-mass spectrometry

Lu Y et al. · Journal of pharmaceutical and biomedical analysis

Added to ASH registry: 2026-05-28

Coagulation factor XI and coronary artery disease: is there room for factor XI inhibitors?

Paszek et al. · Polish archives of internal medicine

Added to ASH registry: 2026-05-28

Collaboration on the optimal timing of anticoagulation after ischaemic stroke and atrial fibrillation: a systematic review and prospective individual participant data meta-analysis of randomised controlled trials (CATALYST).

Dehbi et al. · Lancet (London, England)

Added to ASH registry: 2026-05-28

Comparative Analysis of Thrombosis in ECPella Patients Between Bivalirudin versus Heparin Anticoagulation Strategies

Cho AJ et al. · Journal of cardiothoracic and vascular anesthesia

Added to ASH registry: 2026-05-28

Comparative effectiveness and safety of rivaroxaban with other oral anticoagulants in older adults with nonvalvular atrial fibrillation: population-based analysis in response to updated Beers Criteria

Dawwas et al. · Journal of thrombosis and haemostasis : JTH

Added to ASH registry: 2026-05-28

Comparative safety and effectiveness of apixaban and rivaroxaban for treatment of cancer-associated venous thromboembolism: A retrospective cohort study

Sun et al. · PLoS medicine

Added to ASH registry: 2026-05-28

Comparative Study of Hirudins and Encoding Genes inand

Yin J et al. · Biology

Added to ASH registry: 2026-05-28

Comparison of outcomes of arterial end-to-side versus end-to-end anastomosis in autologous deep inferior epigastric perforator (DIEP) flap breast reconstruction: DIEP-ES study protocol.

Didzun et al. · International journal of surgery protocols

Added to ASH registry: 2026-05-28

Comparison of safety and efficacy of ultrasound-accelerated thrombolysis vs. standard catheter-directed thrombolysis for the management of acute pulmonary embolism - a systematic review and meta-analysis.

Passey et al. · Journal of thrombosis and thrombolysis

Added to ASH registry: 2026-05-28

Comparison of Three Mathematical Models of the Pharmacokinetics of Heparin to Guide the Use of Protamine in a Large Simulated Cohort of Patients

Vander Zwaag et al. · Seminars in cardiothoracic and vascular anesthesia

Added to ASH registry: 2026-05-28

Complement function and activation in human serum and plasma collected in different blood collection tubes

Andersson LI et al. · Journal of immunological methods

Added to ASH registry: 2026-05-28

Considerations of safety for women prescribed apixaban or rivaroxaban who breastfeed-a physiologically based pharmacokinetic analysis

Butler AS et al. · Journal of thrombosis and haemostasis : JTH

Added to ASH registry: 2026-05-28

Construction of safer hirudin-derived peptides with enhanced anticoagulant properties based on C-terminal active residue adaptation and modification

Yi X et al. · Journal of advanced research

Added to ASH registry: 2026-05-28

Contemporary management of acute pulmonary embolism.

Guarnieri et al. · International journal of cardiology

Added to ASH registry: 2026-05-28

Correction: Monitoring the appropriate prescription of low molecular weight heparins and Fondaparinux through administrative data. A retrospective observational study in the Tuscany region

Moretti et al. · PloS one

Added to ASH registry: 2026-05-28

Corrigendum to 'Impact of asundexian on a panel of coagulation assays'[Research and Practice in Thrombosis and Haemostasis 9(5) (2025) 102950]

Vassart et al. · Research and practice in thrombosis and haemostasis

Added to ASH registry: 2026-05-28

Delayed Administration of Apixaban, but Not Rivaroxaban, Reduces Transfusion Risk Without Increasing Thromboembolic Rates Following Revision Total Hip Arthroplasty

Telang et al. · The Journal of arthroplasty

Added to ASH registry: 2026-05-28

Design and Evaluation of Sticky End-Type Bivalent DNA Aptamers Containing M08s-1 as Anticoagulant Agents

Yokomori et al. · ChemMedChem

Added to ASH registry: 2026-05-28

Design, synthesis, and anti-inflammatory potential of PROTAC drug molecules based on fondaparinux sodium

Wu et al. · Frontiers in bioengineering and biotechnology

Added to ASH registry: 2026-05-28

Design, synthesis, and biological evaluation of substituted oxopyridine derivatives as selective FXIa inhibitors

Wang et al. · RSC medicinal chemistry

Added to ASH registry: 2026-05-28

Direct Oral Anticoagulants Versus Low-Molecular-Weight Heparin in Patients With Cancer-Associated Thrombosis: A Meta-Analysis of Randomized Controlled Trials.

Mousavi et al. · The American journal of cardiology

Added to ASH registry: 2026-05-28

Discovery of potent, highly selective, and orally bioavailable factor XIa inhibitors for anticoagulant therapy

Zhang et al. · European journal of medicinal chemistry

Added to ASH registry: 2026-05-28

DOAC-Stop reverses the anticoagulant effect of asundexian and milvexian

Fitzpatrick et al. · Journal of thrombosis and haemostasis : JTH

Added to ASH registry: 2026-05-28

Dose response of nafamostat mesylate for anticoagulation monitoring in pediatric critical care during continuous venovenous hemodiafiltration

Lee et al. · Scientific reports

Added to ASH registry: 2026-05-28

EASL Clinical Practice Guidelines on vascular diseases of the liver.

? et al. · Journal of hepatology

Added to ASH registry: 2026-05-28

Ecarin-based coagulation monitoring of argatroban in patients with heparin-induced thrombocytopenia: a prospective observational study

Schiferer A et al. · British journal of anaesthesia

Added to ASH registry: 2026-05-28

Edoxaban-induced acute interstitial nephritis

Gen et al. · CEN case reports

Added to ASH registry: 2026-05-28

Effect of concurrent use of rivaroxaban or apixaban with amiodarone on international normalised ratio: a retrospective observational study

Kho C et al. · Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis

Added to ASH registry: 2026-05-28

Effect of heparins, direct oral anticoagulants, and factor XII/factor XI inhibitors on catheter-initiated thrombin generation in platelet-rich plasma: an in vitro study

Hardy et al. · Journal of thrombosis and haemostasis : JTH

Added to ASH registry: 2026-05-28

Effect of vepdegestrant, a PROTAC oestrogen receptor degrader, on dabigatran and rosuvastatin pharmacokinetics in healthy participants

Yang et al. · British journal of clinical pharmacology

Added to ASH registry: 2026-05-28

Effectiveness and safety of bivalirudin anticoagulation therapy in adult patients receiving extracorporeal membrane oxygenation: A systematic review and meta-analysis.

Hu et al. · Medicine

Added to ASH registry: 2026-05-28

Effectiveness and Safety of Rivaroxaban Versus Warfarin in Venous Thromboembolism Patients with Comorbid Obstructive Sleep Apnea: A Retrospective Cohort Study

Coleman et al. · Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis

Added to ASH registry: 2026-05-28

Effects of milvexian alone or with heparin on catheter-induced clotting and thrombin generation

Yin et al. · Journal of thrombosis and haemostasis : JTH

Added to ASH registry: 2026-05-28

Efficacy and Safety of Andexanet Alfa Versus Four Factor Prothrombin Complex Concentrate for Emergent Reversal of Factor Xa Inhibitor Associated Intracranial Hemorrhage: A Systematic Review and Meta-Analysis.

Sarhan et al. · Neurocritical care

Added to ASH registry: 2026-05-28

Efficient Small-Molecule Reversal Agents for Anticoagulant Fondaparinux.

Carbajo et al. · ACS pharmacology & translational science

Added to ASH registry: 2026-05-28

Epidemiology of venous thromboembolism: implications for clinical practice.

Marschang et al. · Polish archives of internal medicine

Added to ASH registry: 2026-05-28

Evaluating the Safety and Efficacy of Asundexian in Cardiovascular Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Arif et al. · Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis

Added to ASH registry: 2026-05-28

Evaluation of a Standardized Electronic Argatroban Dosing Nomogram for Heparin-Induced Thrombocytopenia: A Retrospective Study.

Francis E et al. · The American journal of nursing

Added to ASH registry: 2026-05-28

Evaluation of Antiviral Activity of Lactoferrin in Bovine Milk Toward Fondaparinux Using Ordered Porous Layer Interferometry

Zhang et al. · Analytical chemistry

Added to ASH registry: 2026-05-28

Evolution of neutrophil extracellular traps in the pathology of stroke

Ning W et al. · Neural regeneration research

Added to ASH registry: 2026-05-28

Explore potential immune-related targets of leeches in the treatment of type 2 diabetes based on network pharmacology and machine learning

Hu et al. · Frontiers in genetics

Added to ASH registry: 2026-05-28

Factor Xa Inhibitors and Low Molecular Weight Heparins in Perioperative Surgical Thromboprophylaxis: A Network Meta-analysis

Bajpai et al. · Cardiovascular & hematological agents in medicinal chemistry

Added to ASH registry: 2026-05-28

Factor XI inhibitors and atrial fibrillation: imminent breakthrough or false start?

Raffo et al. · European heart journal supplements : journal of the European Society of Cardiology

Added to ASH registry: 2026-05-28

Factor XI/XIa inhibitors for splanchnic vein thrombosis associated with liver cirrhosis: Is there any potential role?

PorresAguilar et al. · Revista de gastroenterologia de Mexico (English)

Added to ASH registry: 2026-05-28

Factor XI/XIa Inhibitors: A New Approach to Anticoagulation

Whiteson et al. · Cardiology in review

Added to ASH registry: 2026-05-28

Factor XI/XIa inhibitors: a potential solution to anticoagulation dilemmas

Gibson et al. · Expert opinion on pharmacotherapy

Added to ASH registry: 2026-05-28

FDA approves first factor XIIa inhibitor, for hereditary angioedema

Mullard et al. · Nature reviews. Drug discovery

Added to ASH registry: 2026-05-28

Fondaparinux Approval in Pediatrics: The Story of My Third Child

Young. · Pediatric blood & cancer

Added to ASH registry: 2026-05-28

Functional characterization of a common XIa inhibitory Kunitz-domain Shp4 from nine schistosoma secreted proteins with diverse C-terminal fragments

Ye et al. · PLoS neglected tropical diseases

Added to ASH registry: 2026-05-28

Guided reversal of dabigatran in massive hemorrhagic shock

Fernndez et al. · Medicina intensiva

Added to ASH registry: 2026-05-28

Haemophilia.

Chowdary P et al. · Lancet (London, England)

Added to ASH registry: 2026-05-28

Heparin and Direct Oral Anticoagulants have Different Effects on the Phases of Activation and Spatial Spread of Blood Coagulation

Ataullakhanov et al. · Thrombosis and haemostasis

Added to ASH registry: 2026-05-28

Heparin Resistance in Cardiac Surgery with Cardiopulmonary Bypass: Mechanisms, Clinical Implications, and Evidence-Based Management.

Rivera Jiménez et al. · Medicina (Kaunas, Lithuania)

Added to ASH registry: 2026-05-28

Herb-Drug Interaction Between Sailuotong and Pitavastatin: A Systematic Pharmacokinetic Investigation and Mechanism Analysis

Zhang et al. · Drug design, development and therapy

Added to ASH registry: 2026-05-28

Hirudin Alleviates Early Brain Injury After Subarachnoid Hemorrhage in Rats via Regulating NLRP3 Inflammasome-Mediated Pyroptosis

Pan M et al. · Physiological research

Added to ASH registry: 2026-05-28

Hirudin alleviates renal fibrosis by inducing autophagy to suppress NLRP3 inflammasome activation

Long C et al. · Bioscience, biotechnology, and biochemistry

Added to ASH registry: 2026-05-28

How I diagnose and treat acute infection-associated purpura fulminans.

Bendapudi et al. · Blood

Added to ASH registry: 2026-05-28

Impact of Age and Factor Xa Inhibitor Concentrations on Bleeding Risk in Patients with Atrial Fibrillation

Lin et al. · Clinical pharmacology and therapeutics

Added to ASH registry: 2026-05-28

Impact of asundexian on a panel of coagulation assays

Vassart et al. · Research and practice in thrombosis and haemostasis

Added to ASH registry: 2026-05-28

Impact of Banhabaekchulcheonmatang (Banxia Baizhu Tianma Tang) and Hwangryeonhaedoktang (Huang Lian Jie Du Tang) on edoxaban: Herb-drug interaction study in healthy subjects

Cho et al. · Journal of ethnopharmacology

Added to ASH registry: 2026-05-28

Impact of Prophylactic Apixaban for 14 Days After Sleeve Gastrectomy on Thromboembolic Events and Its Side Effects

Galvao et al. · Obesity surgery

Added to ASH registry: 2026-05-28

Impairment of Collagen-Induced Thrombus Formation in Microfluidic Assay Correlates with Bleeding Complications Better Than Cytofluorometric Parameters

Melnikova EA et al. · Thrombosis and haemostasis

Added to ASH registry: 2026-05-28

Inappropriate dosing of direct oral anticoagulants among very older inpatients with atrial fibrillation

Zhang et al. · BMC geriatrics

Added to ASH registry: 2026-05-28

Independent and interactive roles of hirudin and HMGB1 interference in protecting renal function by regulating autophagy, apoptosis, and kidney injury in chronic kidney disease

Li Y et al. · European journal of histochemistry : EJH

Added to ASH registry: 2026-05-28

Individualizing Thromboprophylaxis: From Fixed Doses to Targeted Low-Molecular-Weight Heparin Use

Kotsiou OS et al. · Cardiovascular drugs and therapy

Added to ASH registry: 2026-05-28

Inhibition of Activated Coagulation Factor XII by the Phosphodiesterase-4 Inhibitor Roflumilast: In Vitro and In Silico Studies

Madkhali et al. · Frontiers in bioscience (Landmark edition)

Added to ASH registry: 2026-05-28

Interferences associated with the factor XIa inhibitors asundexian and milvexian in routine and specialized coagulation assays and their removal by activated charcoal-based adsorbents

Buckley et al. · Journal of thrombosis and haemostasis : JTH

Added to ASH registry: 2026-05-28

Intra-Arterial Tenecteplase Following Endovascular Reperfusion for Large Vessel Occlusion Acute Ischemic Stroke: The POST-TNK Randomized Clinical Trial.

Huang J et al. · JAMA

Added to ASH registry: 2026-05-28

Intraoperative antithrombotic drug removal during heart transplantation: A case series from the International Safe and Timely Antithrombotic Removal (STAR) registry

Schmitto et al. · JHLT open

Added to ASH registry: 2026-05-28

Intravenous Tenecteplase before Thrombectomy in Stroke.

Qiu Z et al. · The New England journal of medicine

Added to ASH registry: 2026-05-28

Investigation into the binding domains of platelet factor 4 unlocks new avenues for the design and synthesis of selective sulfated pseudo-tetrasaccharide aminoglycoside ligands

Philip et al. · European journal of medicinal chemistry

Added to ASH registry: 2026-05-28

Is fondaparinux safe for use during pregnancy? A state-of-the-art review of current evidence

Wu et al. · Archives of gynecology and obstetrics

Added to ASH registry: 2026-05-28

Left atrial appendage closure vs oral anticoagulation for stroke prevention in atrial fibrillation: Long-term outcomes from 4 randomized trials.

Kaisaier et al. · Heart rhythm

Added to ASH registry: 2026-05-28

Left atrial appendage occlusion in atrial fibrillation: shaping the future of stroke prevention.

Mitsis A et al. · Future cardiology

Added to ASH registry: 2026-05-28

Low concentrations of recombinant activated factor VII normalize coagulation patterns by reversing the changes in viscoelastic testing parameters induced by abelacimab in vitro

Khder et al. · Research and practice in thrombosis and haemostasis

Added to ASH registry: 2026-05-28

Low-molecular-weight heparin-induced thrombocytopenia with multisite embolism: successful management with argatroban and dabigatran - a case report and literature review

Zhao et al. · Frontiers in pharmacology

Added to ASH registry: 2026-05-28

Maculopathy after long-term use of fondaparinux, a heparin mimetic and heparanase inhibitor

Lin et al. · American journal of ophthalmology case reports

Added to ASH registry: 2026-05-28

Medicinal Leech Therapy in Acute Herpes Zoster Condition- A Case Report

Itankar PB et al. · Journal of pharmacy & bioallied sciences

Added to ASH registry: 2026-05-28

Molecular characterization and immunological functions of the antimicrobial peptide theromacin from razor clam Sinonovacula constricta.

Hu H et al. · International journal of biological macromolecules

Added to ASH registry: 2026-05-28

Mortality, diagnosis, and etiology of disseminated intravascular coagulation-a systematic review and meta-analysis: communication from the ISTH SSC subcommittee on disseminated intravascular coagulation.

Umemura et al. · Journal of thrombosis and haemostasis : JTH

Added to ASH registry: 2026-05-28

NEJM at ESC - Asundexian versus Apixaban in Patients with Atrial Fibrillation

Rubin et al. · The New England journal of medicine

Added to ASH registry: 2026-05-28

Occurrence of Platelet-Monocyte Aggregates in Patients with Metabolic Disorders and Effect of Direct Anticoagulants

Gunaseelan et al. · Thrombosis and haemostasis

Added to ASH registry: 2026-05-28

Oral anticoagulant reversal and mortality in trauma patients: a multicentre propensity score-matched cohort study

Lang et al. · EClinicalMedicine

Added to ASH registry: 2026-05-28

Oral anticoagulation versus no anticoagulation for stroke prevention in patients with intracranial haemorrhage and atrial fibrillation: an updated meta-analysis of randomised controlled trials.

D'Anna et al. · Journal of neurology, neurosurgery, and psychiatry

Added to ASH registry: 2026-05-28

Oral factor xia inhibitor milvexian after a recent acute coronary syndrome: Rationale and design of the phase 3 (Librexia ACS)

Gibson et al. · American heart journal

Added to ASH registry: 2026-05-28

Pentasaccharide anticoagulant fondaparinux inhibits diphtheria toxin

Heber et al. · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Added to ASH registry: 2026-05-28

Perioperative Factor Xa Inhibitor Discontinuation for Patients Undergoing Procedures With Minimal or Low Bleeding Risk

Lee et al. · JAMA network open

Added to ASH registry: 2026-05-28

Pharmacokinetic prediction and dosage adjustment of enoxaparin administration in pregnant women with renal insufficiency: A FAERS-PBPK modeling study

Guo G et al. · Journal of pharmaceutical sciences

Added to ASH registry: 2026-05-28

Pharmacokinetics, pharmacodynamics and safety profile of SKB336, a selective inhibitor of coagulation factor XI/XIa in healthy subjects

Xiang et al. · British journal of clinical pharmacology

Added to ASH registry: 2026-05-28

Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Milvexian in Healthy Chinese Adults

Luo et al. · Drug design, development and therapy

Added to ASH registry: 2026-05-28

Population Pharmacokinetics of Asundexian in People at Risk for Thromboembolic/Cardiovascular Events

Yassen et al. · CPT: pharmacometrics & systems pharmacology

Added to ASH registry: 2026-05-28

Position statement of the Polish Society of Gastroenterology on the use of andexanet alfa in patients with gastrointestinal bleeding taking factor Xa inhibitors

Adrych K et al. · Przeglad gastroenterologiczny

Added to ASH registry: 2026-05-28

Postoperative Direct Oral Anticoagulants are Associated with Improved Amputation-Free Survival in Infrageniculate Bypasses Performed by Prosthetic Grafts in Patients with Chronic Limb-Threatening Ischemia

Zarrintan et al. · Annals of vascular surgery

Added to ASH registry: 2026-05-28

Predicting drug-drug interactions and optimal dosing of betrixaban with physiologically based pharmacokinetic modeling in patients with renal impairment who were coadministered with P-glycoprotein inhibitors

Yan et al. · The Journal of international medical research

Added to ASH registry: 2026-05-28

Primary Anticoagulation With Bivalirudin Versus Heparin for Microaxial Flow Pump Supported Patients

Gramegna M et al. · ASAIO journal (American Society for Artificial Internal Organs : 1992)

Added to ASH registry: 2026-05-28

Proposal for a tooth extraction protocol for patients taking direct oral anticoagulants: a clinical trial

Higashi EM et al. · Oral surgery, oral medicine, oral pathology and oral radiology

Added to ASH registry: 2026-05-28

Proteolytic signatures of coagulation identified by plasma peptidomics

Del Castillo Alferez J et al. · Journal of thrombosis and haemostasis : JTH

Added to ASH registry: 2026-05-28

Radial Access and Fondaparinux: A Synergistic Interaction

Andrade et al. · Arquivos brasileiros de cardiologia

Added to ASH registry: 2026-05-28

Rapid clearance of achiral small-molecule drugs using de novo-designed proteins and their cyclic and mirror-image variants.

Chen G et al. · Nature biomedical engineering

Added to ASH registry: 2026-05-28

Rapid Determination of Xa Inhibitor Activity in Blood Using a Microfluidic Device that Measures Platelet Deposition and Fibrin Generation Under Flow

Rossi et al. · TH open : companion journal to thrombosis and haemostasis

Added to ASH registry: 2026-05-28

Real-world evaluation of therapeutic anticoagulation for cancer-associated thromboembolism: A retrospective analysis.

Chung J et al. · Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Added to ASH registry: 2026-05-28

Rebalancing agents in hemophilia: knowns, unknowns, and uncertainties.

Van Thillo et al. · Haematologica

Added to ASH registry: 2026-05-28

Refractory autoimmune heparin-induced thrombocytopenia following cardiac surgery

Zlamal et al. · Journal of thrombosis and haemostasis : JTH

Added to ASH registry: 2026-05-28

Reversal of antithrombotic medications in patients with traumatic brain injury: What you need to know

Popma et al. · The journal of trauma and acute care surgery

Added to ASH registry: 2026-05-28

Reversal of Factor Xa Inhibitor-Related Intracranial Hemorrhage: A Multicenter, Retrospective, Observational Study Comparing the Efficacy and Safety of Andexanet and Prothrombin Complex Concentrates.

Panos et al. · Critical care medicine

Added to ASH registry: 2026-05-28

Revisiting Heparin-Induced Thrombocytopenia among Patients Undergoing Free Tissue Transfer: A Systematic Review.

Yamin et al. · Journal of reconstructive microsurgery

Added to ASH registry: 2026-05-28

Rivaroxaban vs. Enoxaparin for Preventing Venous Thromboembolism and Wound Complications after Knee Surgery: A Meta-Analysis

He et al. · Journal of the College of Physicians and Surgeons--Pakistan : JCPSP

Added to ASH registry: 2026-05-28

Safety of Factor XI Inhibition With Abelacimab in Atrial Fibrillation by Kidney Function: A Prespecified Analysis of the AZALEA-TIMI 71 Randomized Clinical Trial

Patel et al. · JAMA cardiology

Added to ASH registry: 2026-05-28

Safety Profile and Bleeding Complications of Fondaparinux Versus Enoxaparin in Non-ST Elevation Acute Coronary Syndrome

Rahman et al. · Cureus

Added to ASH registry: 2026-05-28

Splanchnic vein thrombosis (2003-2022): a Swiss nationwide epidemiological study.

Cardi et al. · Thrombosis research

Added to ASH registry: 2026-05-28

Splanchnic vein thrombosis in patients with pancreatitis: Outcome and impact of anticoagulation.

Maire et al. · Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]

Added to ASH registry: 2026-05-28

Structure-based design and synthesis of novel FXIa inhibitors targeting the S2' subsite for enhanced antithrombotic efficacy

Wu et al. · Molecular diversity

Added to ASH registry: 2026-05-28

Subclinical atrial fibrillation: Who benefits from oral anticoagulation?

Atar et al. · Kardiologia polska

Added to ASH registry: 2026-05-28

Successful Treatment With the Oral Factor Xa Inhibitor Edoxaban in Heparin-Induced Thrombocytopenia With Thrombosis

Porres-Aguilar et al. · Angiology

Added to ASH registry: 2026-05-28

Superficial Vein Thrombosis: A Review.

Piazza et al. · JAMA

Added to ASH registry: 2026-05-28

TEG and ROTEM: Technology and Clinical Applications, 2026 Update.

Longacre et al. · American journal of hematology

Added to ASH registry: 2026-05-28

Tenecteplase vs Reteplase in Patients with Acute ST-Elevation Myocardial Infarction: A Retrospective Cohort Study.

Mohamed A et al. · Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis

Added to ASH registry: 2026-05-28

The Discovery of a Novel Anticoagulant Mechanism: Factor XI Activation Inhibitors

Ellsworth et al. · ACS pharmacology & translational science

Added to ASH registry: 2026-05-28

The Effects of Heparin Binding and Arg596 Mutations on the Conformation of Thrombin-Antithrombin Michaelis Complex, Revealed by Enhanced Sampling Molecular Dynamics Simulations.

Balogh G et al. · International journal of molecular sciences

Added to ASH registry: 2026-05-28

The genetic spectrum of rare bleeding disorders.

Mohsenian et al. · Journal of thrombosis and haemostasis : JTH

Added to ASH registry: 2026-05-28

The incidence of venous thromboembolism by type of solid cancer worldwide: A systematic review.

Harry et al. · Cancer epidemiology

Added to ASH registry: 2026-05-28

The nacre protein Hcperlucin provides antibacterial defense following Aeromonas hydrophila infection and crystal morphological modification during shell biomineralization in Hyriopsis cumingii.

Tan X et al. · Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology

Added to ASH registry: 2026-05-28

The routine use of Rivaroxaban as thromboprophylaxis following endovenous thermal ablation

Bontinis et al. · VASA. Zeitschrift fur Gefasskrankheiten

Added to ASH registry: 2026-05-28

The safety and efficacy of factor XIa inhibitors for the prevention of stroke and thromboembolism: A systematic review and meta-analysis of randomized controlled trials

Zahid et al. · Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association

Added to ASH registry: 2026-05-28

Thrombolysis Alone vs With Argatroban or Eptifibatide: A Prespecified Subgroup Analysis of the MOST Trial

Roy et al. · Neurology

Added to ASH registry: 2026-05-28

Thrombolysis for Ischemic Stroke Beyond the 4.5-Hour Window: A Meta-Analysis of Randomized Clinical Trials.

Günkan A et al. · Stroke

Added to ASH registry: 2026-05-28

Thrombosis and bleeding outcomes with warfarin conversion to rivaroxaban during the COVID-19 pandemic

Wang et al. · South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde

Added to ASH registry: 2026-05-28

Time to hemostatic agent administration increases mortality in veterans with factor Xa inhibitor-related intracranial hemorrhage

Markovic N et al. · The American journal of emergency medicine

Added to ASH registry: 2026-05-28

Treatment of Venous Thromboembolism with Edoxaban over 18 Months: Results from ETNA-VTE Europe

Agnelli et al. · Thrombosis and haemostasis

Added to ASH registry: 2026-05-28

Trends and variation in the use of andexanet alfa for the reversal of direct oral anticoagulants in NHS trusts in England

Fisher L et al. · British journal of clinical pharmacology

Added to ASH registry: 2026-05-28

Use of Bivalirudin for a Pediatric Patient with Two Mechanical Heart Valves: a case report

Branstetter JW et al. · Cardiology in the young

Added to ASH registry: 2026-05-28

Use of factor XI/XIa inhibitors in patients with atrial fibrillation: Current progress and future prospects

Fan et al. · Ageing research reviews

Added to ASH registry: 2026-05-28

Utilizing Argatroban for Neuroendovascular Therapy in Heparin-Induced Thrombocytopenia: A Case Report and Technical Review

Eguchi et al. · Journal of neuroendovascular therapy

Added to ASH registry: 2026-05-28

Vascular endothelial cell-targeted mRNA delivery via synthetic lipid nanoparticles for venous thrombosis prevention.

Guo et al. · Journal of controlled release : official journal of the Controlled Release Society

Added to ASH registry: 2026-05-28

Venous Thromboembolism Chemoprophylaxis in Plastic Surgery: A Randomized Controlled Trial of Apixaban versus Enoxaparin

Momeni et al. · Plastic and reconstructive surgery

Added to ASH registry: 2026-05-28

Venous Thromboembolism Therapy with Edoxaban in Daily Care Patients: Results from the DRESDEN NOAC REGISTRY.

Tittl et al. · TH open : companion journal to thrombosis and haemostasis

Added to ASH registry: 2026-05-28

Volume and Location Analysis of Intracerebral Hemorrhage for the Appropriate Use of Andexanet Alfa

Umemura T et al. · Neurologia medico-chirurgica

Added to ASH registry: 2026-05-28

Weekly Journal Scan: the rise and OCEANIC fall of asundexian in atrial fibrillation

Liuzzo et al. · European heart journal

Added to ASH registry: 2026-05-28

Whole-genome sequencing-based species classification, multilocus sequence typing, and antibiotic resistance mechanisms of the clinicalcomplex.

Lu J et al. · Frontiers in microbiology

Added to ASH registry: 2026-05-28

A biomimetic macrophage-membrane-fused liposomal system loaded with GVs-HV recombinant plasmid for targeted anti-atherosclerosis therapy

Zhang Y et al. · Pharmaceutics

Added to ASH registry: 2026-05-27

A Comparative Analysis of Bivalirudin and Heparin for Extracorporeal Membrane Oxygenation in a Pediatric Cardiothoracic Intensive Care Unit

Daniels Z et al. · ASAIO journal

Added to ASH registry: 2026-05-27

Analysis of inter-hospital transfer on clinical outcomes after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction

Su X et al. · PLoS medicine

Added to ASH registry: 2026-05-27

Anticoagulants in children with renal impairment: a narrative review

Kiskaddon AL et al. · Seminars in thrombosis and hemostasis

Added to ASH registry: 2026-05-27

Anticoagulants in Children with Renal Impairment: A Narrative Review

Kiskaddon AL et al. · Seminars in Thrombosis and Hemostasis

Added to ASH registry: 2026-05-27

Anticoagulants: from chance discovery to structure-based design

Chan N et al. · Pharmacological reviews

Added to ASH registry: 2026-05-27

Anticoagulation for heparin-induced thrombocytopenia before, during, and after peripheral endovascular procedures

Cardi S et al. · VASA

Added to ASH registry: 2026-05-27

Anticoagulation for heparin-induced thrombocytopenia before, during, and after peripheral endovascular procedures

Cardi S et al. · VASA — Zeitschrift fur Gefasskrankheiten

Added to ASH registry: 2026-05-27

Application of promoting blood circulation and resolving blood stasis in intracerebral hemorrhage: a traditional method gradually moving toward modern stroke care

Dingshan Z et al. · Journal of traditional Chinese medicine

Added to ASH registry: 2026-05-27

Argatroban plus dual antiplatelet therapy: Preliminary evidence for managing early neurological deterioration after lacunar stroke

Zhang H et al. · Clinical neurology and neurosurgery

Added to ASH registry: 2026-05-27

Bivalirudin infusion at standard or low regimen during elective percutaneous coronary intervention in high-risk bleeding patients

Li Y et al. · Contemporary clinical trials

Added to ASH registry: 2026-05-27

Bivalirudin versus heparin in patients undergoing percutaneous coronary intervention in acute coronary syndromes

Krittanawong C et al. · Critical pathways in cardiology

Added to ASH registry: 2026-05-27

Bloodletting therapy using subcutaneous heparin and controlled scarification for venous insufficiency in free flap reconstruction

Yalcin CE · Microsurgery

Added to ASH registry: 2026-05-27

BMI differences on anticoagulation with bivalirudin vs. heparin during primary PCI: a BRIGHT-4 subanalysis

Zhang D et al. · BMC medicine

Added to ASH registry: 2026-05-27

Catheter-Directed Bivalirudin for Local Anticoagulation and Clot Dissolution in Children Requiring Mechanical Circulatory Support

Chaudhry-Waterman N et al. · ASAIO journal

Added to ASH registry: 2026-05-27

Chromosome-level genome assembly and anticoagulant protein annotation of the buffalo leech Hirudinaria bpling (Hirudinea: Hirudinidae)

Khan MS et al. · BMC genomics

Added to ASH registry: 2026-05-27

Chromosome-level genome assembly and anticoagulant protein annotation of the buffalo leech Hirudinaria bpling (Hirudinea: Hirudinidae)

Khan MS et al. · BMC Genomics

Added to ASH registry: 2026-05-27

Comparative analysis of anti-thrombotic effect and metabonomic mechanism of aqueous extract of leech before and after talc processing

Liu Y et al. · Zhongguo Zhong yao za zhi

Added to ASH registry: 2026-05-27

Comparative Study of Lefaxin Family in Two Asian Leeches:and

Ye T et al. · Biology

Added to ASH registry: 2026-05-27

Dabigatran-idarucizumab pharmacokinetics-pharmacodynamics in sheep undergoing cardiopulmonary bypass

Eaton MP et al. · Perfusion

Added to ASH registry: 2026-05-27

Discovery of a Thrombin-Targeting Anticoagulant Peptide From Whitmania pigra via a Computation-Guided Experimentation Strategy

Hua Y et al. · Journal of peptide science

Added to ASH registry: 2026-05-27

Distribution and blood penetration of hirudin in various organs and tissues of rabbits with carotid artery injury

Feng Y et al. · Journal of analytical methods in chemistry

Added to ASH registry: 2026-05-27

Dosing Reliability of Direct Thrombin Inhibitors in Extracorporeal Membrane Oxygenation: A Systematic Review and Meta-Analysis

Wieruszewski PM et al. · ASAIO journal (American Society for Artificial Internal Organs : 1992)

Added to ASH registry: 2026-05-27

Engineering ultrapotent trivalent anticoagulants through hybridisation of salivary peptides from multiple haematophagous organisms

Maxwell JWC et al. · Chemical science

Added to ASH registry: 2026-05-27

Evaluation of a Bivalirudin Dosing and Monitoring Protocol in Pediatric Extracorporeal Membrane Oxygenation

Smith LM et al. · The journal of pediatric pharmacology and therapeutics

Added to ASH registry: 2026-05-27

Evaluation of Intraoperative Bivalirudin Anticoagulation in Neonates and Infants Undergoing Arterial Switch Operation on Integrated ECMO-CPB Circuit: A Prospective Study

Badge HM et al. · Journal of cardiothoracic and vascular anesthesia

Added to ASH registry: 2026-05-27

Expression of Recombinant Hirudin in Bacteria and Yeast: A Comparative Approach

Wang Z et al. · Methods Protoc

Added to ASH registry: 2026-05-27

Hemocompatibility related complications in Impella 5+ patients treated with Bivalirudin and dual antiplatelet therapy: a SHEAR score evaluation

Bandini M et al. · Cardiovascular revascularization medicine

Added to ASH registry: 2026-05-27

Hemolysis Monitoring Practices during Extracorporeal Membrane Oxygenation: A Survey Report

Strong AE et al. · Blood purification

Added to ASH registry: 2026-05-27

Heparin Induced Thrombocytopenia In The Setting Of Urgent Cardiac Surgery: Can Bivalirudin Be A Safe Option? - A Case Report

Alves B et al. · Portuguese Journal of Cardiac Thoracic and Vascular Surgery

Added to ASH registry: 2026-05-27

Heparin Versus Bivalirudin in Pediatric Patients Assisted With Mechanical Circulatory Support: A Retrospective Before-and-after Study

Giorni C et al. · Journal of cardiothoracic and vascular anesthesia

Added to ASH registry: 2026-05-27

Heparin Versus Bivalirudin in Pediatric Patients Assisted With Mechanical Circulatory Support: A Retrospective Before-and-after Study

Giorni C et al. · Journal of Cardiothoracic and Vascular Anesthesia

Added to ASH registry: 2026-05-27

Hirudin promotes cerebral angiogenesis and exerts neuroprotective effects in MCAO/R rats by activating the Wnt/-catenin pathway

He L et al. · J Stroke Cerebrovasc Dis

Added to ASH registry: 2026-05-27

Hirudin-based treatment of diabetes-induced erectile dysfunction through inhibition of the HIF-1α to regulate RhoA/ROCK signaling pathway

Sun L et al. · American journal of men's health

Added to ASH registry: 2026-05-27

Identification and Screening of Novel Antimicrobial Peptides from Medicinal Leech via Heterologous Expression in E. coli

Serebrennikova M et al. · International journal of molecular sciences

Added to ASH registry: 2026-05-27

Impact of pre-PCI activated clotting time on outcomes of bivalirudin versus heparin during primary PCI

Liu et al. · Journal of the Society for Cardiovascular Angiography & Interventions

Added to ASH registry: 2026-05-27

Improved outcomes with pulsatile paracorporeal ventricular assist device support in children: A single-center experience

Iaprintsev V et al. · JTCVS Open

Added to ASH registry: 2026-05-27

Leech Extract Enhances the Pro-Angiogenic Effects of Endothelial Cell-Derived Exosomes in a Mouse Model of Ischemic Stroke

Cao Y et al. · Current issues in molecular biology

Added to ASH registry: 2026-05-27

Managing necrotizing soft tissue infections of the lower limb: microsurgical reconstruction and hospital resource demands

Karamitros G et al. · Journal of clinical medicine

Added to ASH registry: 2026-05-27

Molecular cloning and functional analysis of a destabilase from Hirudinaria manillensis

Gao T et al. · Protein expression and purification

Added to ASH registry: 2026-05-27

Monomeric and Oligomeric Decorsins of the Asian Medicinal Leech

Tolksdorf C et al. · International journal of molecular sciences

Added to ASH registry: 2026-05-27

Multi-target anticoagulant regulation by peptides from medicinal leeches: a unique natural strategy

Shi et al. · Pharmaceutical research

Added to ASH registry: 2026-05-27

Multi-Target Anticoagulant Regulation by Peptides from Medicinal Leeches: A Unique Natural Strategy against Thrombosis

Shi P et al. · Pharmaceutical research

Added to ASH registry: 2026-05-27

Outcomes of patients with suspected heparin-induced thrombocytopenia in a contemporary multicenter cohort

Nilius H et al. · Blood advances

Added to ASH registry: 2026-05-27

Platelet derived prothrombotic microparticles and adverse events in patients supported with Impella 5.5

D'Ettore N et al. · The International journal of artificial organs

Added to ASH registry: 2026-05-27

Production and functional characteristics of a novel hirudin variant with better anticoagulant activities than bivalirudin

Ge P et al. · Journal of enzyme inhibition and medicinal chemistry

Added to ASH registry: 2026-05-27

Production and functional characteristics of a novel hirudin variant with better anticoagulant activities than bivalirudin

Ge L et al. · Journal of enzyme inhibition and medicinal chemistry

Added to ASH registry: 2026-05-27

Production, Purification, and Characterization of a Novel Cysteine-Rich Anticoagulant from the Medicinal Leech and the Functional Role of Its Disulfide Bonds

Manuvera VA et al. · Biomolecules

Added to ASH registry: 2026-05-27

Quantitative methods to improve bivalirudin dosing in pediatric cardiac ICU patients

Brinkley L et al. · Perfusion

Added to ASH registry: 2026-05-27

Recombinant hirudin prevents against nonalcoholic fatty liver disease by modulating PAR1/JAK2/STAT5/STAT3/CD36 pathway

Xiaoyu YU et al. · Biochimica et biophysica acta. Molecular and cell biology of lipids

Added to ASH registry: 2026-05-27

Reconstruction of Wagner Grade 4 diabetic foot ulcers with the superficial circumflex iliac artery perforator free flap

Evin N et al. · Microsurgery

Added to ASH registry: 2026-05-27

Retrospective, Single-Center Cohort Study of Bivalirudin Compared to Unfractionated Heparin in Patients Receiving Extracorporeal Membrane Oxygenation

Lofy T et al. · The Annals of pharmacotherapy

Added to ASH registry: 2026-05-27

Safety and Efficacy of Bivalirudin as a Heparin Alternative in Patients Undergoing Carotid Artery Stenting

Kania TA et al. · Annals of vascular surgery

Added to ASH registry: 2026-05-27

Safety and efficacy of bivalirudin in female acute coronary syndrome patients undergoing percutaneous coronary intervention

Mostofa ABM et al. · Mymensingh medical journal

Added to ASH registry: 2026-05-27

Shuxuetong injection inhibits pyroptosis in acute ischemic stroke via CD44/NLRP3/GSDMD signal

Shang J et al. · Journal of ethnopharmacology

Added to ASH registry: 2026-05-27

Shuxuetong injection promotes skin flap survival by inhibiting pyroptosis mediated by the TLR4/NF-B/NLRP3 signaling pathway

Wang K et al. · Journal of ethnopharmacology

Added to ASH registry: 2026-05-27

Species delimitation recovers undescribed Erpobdellidae (Annelida: Hirudinea) from USA and Turkiye

Saglam N et al. · Zootaxa

Added to ASH registry: 2026-05-27

Staged mechanical circulatory support in paediatric HIT: Bivalirudin anticoagulation across ECMO, VAD, and cardiac transplantation

Beeman A et al. · Perfusion

Added to ASH registry: 2026-05-27

Staged mechanical circulatory support in paediatric HIT: Bivalirudin anticoagulation across ECMO, VAD, and cardiac transplantation

Beeman AA et al. · Perfusion

Added to ASH registry: 2026-05-27

Steroid Utilization for Pediatric Ventricular Assist Device-Associated Inflammation and Association With Outcomes

Ankola AA et al. · ASAIO Journal

Added to ASH registry: 2026-05-27

Successful pediatric heart transplantation with bivalirudin use in a cyanotic single ventricle patient with an intracorporeal continuous flow ventricular assist device and heparin-induced thrombocytopenia

Sainathan S, Mulinari L · Indian Journal of Thoracic and Cardiovascular Surgery

Added to ASH registry: 2026-05-27

Supramolecular Prodrug Hydrogel for One-Week Protection Against Thrombosis

Zhang W et al. · Small

Added to ASH registry: 2026-05-27

The derivatives of hirudin-like peptides from the Poecilobdella manillensis exhibit antithrombotic and anti-ischemic stroke effects

Khalid M et al. · International journal of biological macromolecules

Added to ASH registry: 2026-05-27

The effects of bivalirudin and ordinary heparin on the incidence of bleeding events and the level of inflammation after interventional therapy

Wu Q et al. · Alternative therapies in health and medicine

Added to ASH registry: 2026-05-27

The efficacy and safety of bivalirudin and heparin in patients with acute coronary syndrome: a systematic review and meta-analysis

Zhai Y et al. · Systematic reviews

Added to ASH registry: 2026-05-27

Ticagrelor vs. clopidogrel in bivalirudin-treated patients with STEMI undergoing primary PCI: The BRIGHT-4 trial

Li Y et al. · Cardiovascular revascularization medicine

Added to ASH registry: 2026-05-27

Traditional Chinese Medicinal Leech Induces Apoptosis and Autophagy in Glioblastoma by SGK1/Caspase-3 and PI3K/AKT/mTOR Pathway

Wu S et al. · CNS neuroscience & therapeutics

Added to ASH registry: 2026-05-27

Traditional uses, chemical constituents, pharmacological activities and toxicology of Chinese medicinal leech (Shuizhi): A comprehensive review

Liu J et al. · Journal of ethnopharmacology

Added to ASH registry: 2026-05-27

Discovery of a Thrombin-Targeting Anticoagulant Peptide From Whitmania pigra via a 'Computation-Guided Experimentation' Strategy

Hua YT et al. · Journal of peptide science : an official publication of the European Peptide Society

Added to ASH registry: 2026-05-26

Leech bionic Hirudin fusion protein prodrug loaded microneedles for long-term inhibition of thrombosis

Tian X et al. · Journal of controlled release : official journal of the Controlled Release Society

Added to ASH registry: 2026-03-18

Novel drug delivery systems for hirudin-based product development and clinical applications

Mo L et al. · International journal of biological macromolecules

Added to ASH registry: 2026-03-18

A comparative study of the clinical benefits of rivaroxaban and dabigatran in patients with nonvalvular atrial fibrillation with high bleeding risk

Liu · Frontiers in cardiovascular medicine

Added to ASH registry: 2026-05-29

Adverse events of direct factor Xa inhibitors: a disproportionality analysis of the FAERS database

Qian et al. · Expert opinion on drug safety

Added to ASH registry: 2026-05-29

Apixaban vs Aspirin in Patients With Cancer and Cryptogenic Stroke: A Post Hoc Analysis of the ARCADIA Randomized Clinical Trial

Navi et al. · JAMA neurology

Added to ASH registry: 2026-05-29

Application of the Win Ratio Method in the ENGAGE AF-TIMI 48 Trial Comparing Edoxaban With Warfarin in Patients With Atrial Fibrillation

Bergmark et al. · Circulation. Cardiovascular quality and outcomes

Added to ASH registry: 2026-05-29

Appropriateness of direct oral anticoagulant dosing in patients with atrial fibrillation at a tertiary care hospital in Thailand

Pongsathabordee et al. · Exploratory research in clinical and social pharmacy

Added to ASH registry: 2026-05-29

Argatroban Use in Pediatric Patients Supported by Paracorporeal Ventricular Assist Devices

Tuttle et al. · ASAIO journal (American Society for Artificial Internal Organs : 1992)

Added to ASH registry: 2026-05-29

Bivalirudin for unsalvageable venous congestion or obstruction in head and neck free flap reconstruction

Harris et al. · Oral oncology

Added to ASH registry: 2026-05-29

Bivalirudin Stability in Citrated Plasma and Citrated Whole Blood

Bruzdoski et al. · Archives of pathology & laboratory medicine

Added to ASH registry: 2026-05-29

Bivalirudin: The misunderstood alternative to heparin

Faraoni et al. · Paediatric anaesthesia

Added to ASH registry: 2026-05-29

Can the combination of antiplatelet or alteplase thrombolytic therapy with argatroban benefit patients suffering from acute stroke? a systematic review, meta-analysis, and meta-regression

Xie et al. · PloS one

Added to ASH registry: 2026-05-29

Clinical Implications of Co-administering Apixaban with Key Interacting Medications

Favatella et al. · Clinical pharmacology in drug development

Added to ASH registry: 2026-05-29

Comment on: Bivalirudin during thrombolysis with catheter-directed tPA in a heparin-refractory patient: A case report

Han · Pediatric blood & cancer

Added to ASH registry: 2026-05-29

Comparison of Apixaban, Rivaroxaban, Dabigatran, and Vitamin K Antagonists in Patients With Atrial Fibrillation and Liver Disease: A Network Meta-Analysis

Shaikh et al. · Cureus

Added to ASH registry: 2026-05-29

Comparison of bleeding and thrombotic outcomes in veno-venous extracorporeal membrane oxygenation: Heparin versus bivalirudin

Kartika et al. · European journal of haematology

Added to ASH registry: 2026-05-29

Comparison of Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban in Patients With Valvular Atrial Fibrillation: A Network Meta-Analysis of Randomized-Control Trials and Observational Studies

Huma et al. · Cureus

Added to ASH registry: 2026-05-29

Detection of enoxaparin and argatroban by use of the novel viscoelastic coagulometer ClotPro

Gratz et al. · Scientific reports

Added to ASH registry: 2026-05-29

Drug-Drug Interactions in the Treatment of Cancer-Associated Venous Thromboembolism with Direct Oral Anticoagulants

Hellfritzsch et al. · Seminars in thrombosis and hemostasis

Added to ASH registry: 2026-05-29

Editorial: Bivalirudin versus unfractionated heparin in acute myocardial infarction: Why are we still debating?

Cohen et al. · Cardiovascular revascularization medicine : including molecular interventions

Added to ASH registry: 2026-05-29

Edoxaban-Induced Vanishing Bile Duct Syndrome: A Case Report With Review of the Literature

Borgonovo et al. · Cureus

Added to ASH registry: 2026-05-29

Esophageal Damage Following Left Atrial Ablation in a Patient on Dabigatran: Adding Insult to Injury

Jalloul et al. · European journal of case reports in internal medicine

Added to ASH registry: 2026-05-29

Heparin Resistance after Andexanet Alfa - Calling on Argatroban and Nafamostat for Rescue?

Mishima et al. · Journal of cardiothoracic and vascular anesthesia

Added to ASH registry: 2026-05-29

High-Dose Immunoglobulin Therapy for Multiple Thromboembolism in Persisting Heparin-Induced Thrombocytopenia

Kudo et al. · Cureus

Added to ASH registry: 2026-05-29

Intravenous thrombolysis following dabigatran reversal in a patient with acute embolic stroke after atrial fibrillation ablation

Chen et al. · Journal of arrhythmia

Added to ASH registry: 2026-05-29

L-shaped association between gamma-glutamyl transferase-to-albumin ratio and dabigatran-related bleeding in non-valvular atrial fibrillation patients: a multicenter cohort study

Yu et al. · Cardiovascular diagnosis and therapy

Added to ASH registry: 2026-05-29

Long-term effectiveness and safety of edoxaban in patients with atrial fibrillation: 4-year data from the ETNA-AF-Europe study

Kirchhof et al. · International journal of cardiology

Added to ASH registry: 2026-05-29

Management of Bivalirudin Dosing and Replacement Fluid During Therapeutic Plasma Exchange in Children on Extracorporeal Membrane Oxygenation

Chomat et al. · ASAIO journal (American Society for Artificial Internal Organs : 1992)

Added to ASH registry: 2026-05-29

Monitoring Argatroban Anticoagulation in the Critically Ill: All Tests Are Not Created Equal

Erdoes et al. · Anesthesiology

Added to ASH registry: 2026-05-29

Optimizing warfarin dosing for patients with atrial fibrillation using machine learning

Petch et al. · Scientific reports

Added to ASH registry: 2026-05-29

Population pharmacokinetics of unfractionated heparin and multivariable analysis of activated clotting time in patients undergoing radiofrequency ablation of atrial fibrillation

Konecki et al. · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Added to ASH registry: 2026-05-29

Possible Factor Xa Resistance in a Patient Who Failed Apixaban and Rivaroxaban

Ali et al. · Clinical case reports

Added to ASH registry: 2026-05-29

Recombinant hirudin and PAR-1 regulate macrophage polarisation status in diffuse large B-cell lymphoma

Pei et al. · BMC biotechnology

Added to ASH registry: 2026-05-29

Smartphone App for Improving Self-Awareness of Adherence to Edoxaban Treatment in Patients With Atrial Fibrillation (ADHERE-App Trial): Randomized Controlled Trial

Yoon et al. · Journal of medical Internet research

Added to ASH registry: 2026-05-29

The effect of off-label use of reduced-dose direct oral anticoagulants therapy in the treatment of pulmonary embolism comparable to standard-dose therapy

Yamazoe et al. · Heart and vessels

Added to ASH registry: 2026-05-29

UGT2B15 single nucleotide polymorphism reduces dabigatran acylglucuronide formation in humans

Park et al. · Frontiers in pharmacology

Added to ASH registry: 2026-05-29

Unresponsiveness of Activated Partial Thromboplastin Time to Bivalirudin in Adults Receiving Extracorporeal Membrane Oxygenation

Jatis et al. · ASAIO journal (American Society for Artificial Internal Organs : 1992)

Added to ASH registry: 2026-05-29

Use of bivalirudin after initial heparin management among adult patients on long-term venovenous extracorporeal support as a bridge to lung transplant: A case series

Halawi et al. · Pharmacotherapy

Added to ASH registry: 2026-05-29

5-Year Results From the AMPLATZER Amulet Left Atrial Appendage Occluder Randomized Controlled Trial.

Lakkireddy D et al. · Journal of the American College of Cardiology

Added to ASH registry: 2026-05-28

A Comparison Between Fondaparinux Sodium and Low-Molecular-Weight Heparin in Preventing Patients Undergoing Hip Replacement from Deep Vein Thrombosis

Wang et al. · Journal of musculoskeletal & neuronal interactions

Added to ASH registry: 2026-05-28

A narrative review of acute pancreatitis-induced splanchnic vein thrombosis: from pathogenesis to clinical management.

Liu et al. · Scandinavian journal of gastroenterology

Added to ASH registry: 2026-05-28

A pharmacokinetic and pharmacodynamic evaluation of asundexian: a novel factor XIa inhibitor for stroke prevention

Cella et al. · Expert opinion on drug metabolism & toxicology

Added to ASH registry: 2026-05-28

A randomized trial of antithrombotic therapy in patients with acute coronary syndrome and coronary ectasia.

Araiza-Garaygordobil et al. · American heart journal

Added to ASH registry: 2026-05-28

A randomized trial of low-dose thrombolysis, ultrasound-assisted thrombolysis, or heparin for intermediate-high risk pulmonary embolism-the STRATIFY trial: design and statistical analysis plan.

Kjærgaard J et al. · Trials

Added to ASH registry: 2026-05-28

A Rare Case of Argatroban-Induced Anaphylaxis in a Patient With Intermediate-High Risk Pulmonary Embolism

Bulsara KG et al. · Cureus

Added to ASH registry: 2026-05-28

A small-molecule hemostatic agent for the reversal of direct oral anticoagulant-induced bleeding

Desvages et al. · Research and practice in thrombosis and haemostasis

Added to ASH registry: 2026-05-28

Abelacimab: A leap forward in anticoagulation with FXI and FXIa Inhibition

Badreldin et al. · Current research in pharmacology and drug discovery

Added to ASH registry: 2026-05-28

Absolute oral bioavailability of milvexian spray-dried dispersion formulation under fasted and fed conditions in healthy adult participants: An intravenous microtracer approach

Jarugula et al. · Clinical and translational science

Added to ASH registry: 2026-05-28

Allosteric Modulation of Thrombin by Thrombomodulin: Insights from Logistic Regression and Statistical Analysis of Molecular Dynamics Simulations.

Wu D et al. · ACS omega

Added to ASH registry: 2026-05-28

An automated analysis method enabling the screening of covalent thrombin and factor XIIa inhibitors via liquid chromatography-mass spectrometry

Erbacher et al. · Drug testing and analysis

Added to ASH registry: 2026-05-28

Andexanet alfa for reversal of direct factor Xa inhibitor anticoagulation.

Unknown · Australian prescriber

Added to ASH registry: 2026-05-28

Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity: Prespecified Subgroup Analysis of the ANNEXA-4 Study in Japan.

Toyoda et al. · Journal of atherosclerosis and thrombosis

Added to ASH registry: 2026-05-28

Andexanet alfa or prothrombin complex concentrate for acute reversal of oral factor Xa inhibitors: monitoring of antidote effects.

Tanaka et al. · British journal of anaesthesia

Added to ASH registry: 2026-05-28

Andexanet Alfa versus Four-Factor Prothrombin Complex Concentrate for the Reversal of Factor Xa (FXa) Inhibitor-Associated Intracranial Hemorrhage: A Systematic Review of Retrospective Studies.

Ferreira et al. · Journal of clinical medicine

Added to ASH registry: 2026-05-28

Andexanet alfa versus PCC products for factor Xa inhibitor bleeding: A systematic review with meta-analysis

White et al. · Pharmacotherapy

Added to ASH registry: 2026-05-28

Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral Hemorrhage

Yates et al. · The New England journal of medicine

Added to ASH registry: 2026-05-28

Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral Hemorrhage

Wong et al. · The New England journal of medicine

Added to ASH registry: 2026-05-28

Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral Hemorrhage

Kreutziger et al. · The New England journal of medicine

Added to ASH registry: 2026-05-28

Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral Hemorrhage.

Connolly et al. · The New England journal of medicine

Added to ASH registry: 2026-05-28

Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral Hemorrhage. Reply

Shoamanesh et al. · The New England journal of medicine

Added to ASH registry: 2026-05-28

Anti-PF4 ELISA-Negative, SRA-Positive Heparin-Induced Thrombocytopenia.

Attah et al. · Hematology reports

Added to ASH registry: 2026-05-28

Anti-Xa Activity Monitoring for Optimizing Rivaroxaban Dosage in Chinese Patients with Cerebral Venous Thrombosis

Zhang et al. · Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis

Added to ASH registry: 2026-05-28

Anticoagulation Alone vs Anticoagulation Plus Aspirin or DAPT Following Left Atrial Appendage Occlusion.

Reinhardt SW et al. · Journal of the American College of Cardiology

Added to ASH registry: 2026-05-28

Anticoagulation of pediatric patients with venous thromboembolism in 2023.

van Ommen CH et al. · Thrombosis research

Added to ASH registry: 2026-05-28

Anticoagulation reversal (vitamin K, prothrombin complex concentrates, idarucizumab, andexanet-α, protamine).

Bekka E et al. · British journal of clinical pharmacology

Added to ASH registry: 2026-05-28

Antithrombotic prophylaxis following total knee arthroplasty: a level I Bayesian network meta-analysis.

Migliorini et al. · European journal of orthopaedic surgery & traumatology : orthopedie traumatologie

Added to ASH registry: 2026-05-28

Antithrombotic therapy in patients with acute coronary syndrome: similarities and differences between a European expert consensus document and the 2023 European Society of Cardiology guidelines.

Landi et al. · European heart journal. Acute cardiovascular care

Added to ASH registry: 2026-05-28

Application of a Novel UPLC-MS/MS Method for Analysis of Rivaroxaban Concentrations in Dried Blood Spot and Plasma Samples Collected from Patients with Venous Thrombosis

Pawlak et al. · Molecules (Basel, Switzerland)

Added to ASH registry: 2026-05-28

Association of Argatroban Dose With Coagulation Laboratory Test in Patients on Extracorporeal Membrane Oxygenation: Activated Clotting Time vs Activated Partial Thromboplastin Time

Ahn et al. · The Annals of pharmacotherapy

Added to ASH registry: 2026-05-28

Bleeding Complications between Bivalirudin and Heparin for Extracorporeal Membrane Oxygenation in Neonates with Congenital Diaphragmatic Hernia.

Credille et al. · Fetal diagnosis and therapy

Added to ASH registry: 2026-05-28

Bleeding Risk of Anticoagulation Reversal Strategies Before Heart Transplantation: A Retrospective Comparative Cohort Study

PrietoRomero et al. · Journal of cardiovascular development and disease

Added to ASH registry: 2026-05-28

Cancer-associated splanchnic vein thrombosis: Clinical implications and management considerations.

Cohen et al. · Thrombosis research

Added to ASH registry: 2026-05-28

Catastrophic antiphospholipid syndrome: Lessons from the "CAPS Registry".

Rodriguez-Pintó et al. · Medicina clinica

Added to ASH registry: 2026-05-28

Cavernous Sinus Thrombosis.

Housley et al. · Neurosurgery clinics of North America

Added to ASH registry: 2026-05-28

Cerebral microbleeds and asundexian in non-cardioembolic ischemic stroke: Secondary analyses of the PACIFIC-STROKE randomized trial

Balali et al. · International journal of stroke : official journal of the International Stroke Society

Added to ASH registry: 2026-05-28

Cerebral Sinus Venous Thrombosis in Pediatric Acute Lymphoblastic Leukemia: Incidence, Clinical Characteristics, and Long-term Neurologic Outcomes.

Johnson-Bishop et al. · Journal of child neurology

Added to ASH registry: 2026-05-28

Cerebral Venous Sinus Thrombosis: Current Updates in the Asian Context.

Miraclin T et al. · Cerebrovascular diseases extra

Added to ASH registry: 2026-05-28

Cerebral Venous Sinus Thrombosis.

Nguyen et al. · Neurosurgery clinics of North America

Added to ASH registry: 2026-05-28

Clinical guideline on reversal of direct oral anticoagulants in patients with life threatening bleeding

Grottke et al. · European journal of anaesthesiology

Added to ASH registry: 2026-05-28

Clinical outcomes of patients receiving long-term fondaparinux for thrombotic antiphospholipid syndrome

Bor et al. · Lupus

Added to ASH registry: 2026-05-28

Clinical practice guidelines for management of disseminated intravascular coagulation in Japan 2024. Part 1: sepsis.

Yamakawa et al. · International journal of hematology

Added to ASH registry: 2026-05-28

Coagulation Tests and Reversal Agents in Patients Treated with Oral Anticoagulants: The Challenging Scenarios of Life-Threatening Bleeding and Unplanned Invasive Procedures

Pozzi et al. · Journal of clinical medicine

Added to ASH registry: 2026-05-28

Comparative Effectiveness and Safety of Apixaban, Rivaroxaban, and Warfarin in Patients With Cirrhosis and Atrial Fibrillation : A Nationwide Cohort Study

Simon et al. · Annals of internal medicine

Added to ASH registry: 2026-05-28

Comparative Effectiveness of Valoctocogene Roxaparvovec and Prophylactic Factor VIII Replacement in Severe Hemophilia A.

Oldenburg J et al. · Advances in therapy

Added to ASH registry: 2026-05-28

Comparison of anticoagulation vs mechanical thrombectomy for the treatment of iliofemoral deep vein thrombosis.

Abramowitz S et al. · Journal of vascular surgery. Venous and lymphatic disorders

Added to ASH registry: 2026-05-28

Comparison of Fixed Versus Weight-Based Prothrombin Complex Concentrate Dosing Strategies for Factor Xa Inhibitor Reversal

Brett et al. · Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis

Added to ASH registry: 2026-05-28

Comprehensive Review of Tenecteplase for Thrombolysis in Acute Ischemic Stroke.

Wang L et al. · Journal of the American Heart Association

Added to ASH registry: 2026-05-28

Contemporary outcomes of acute ischemic stroke in atrial fibrillation patients on anticoagulation.

Vasquez et al. · Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association

Added to ASH registry: 2026-05-28

Correction of Trauma-induced Coagulopathy by Goal-directed Therapy: A Secondary Analysis of the ITACTIC Trial.

Lindsay et al. · Anesthesiology

Added to ASH registry: 2026-05-28

Dabigatran etexilate versus warfarin in cerebral venous thrombosis in Chinese patients (CHOICE-CVT): An open-label, randomized controlled trial

Ma et al. · International journal of stroke : official journal of the International Stroke Society

Added to ASH registry: 2026-05-28

Demystifying the Contemporary Role of 12-Month Dual Antiplatelet Therapy After Acute Coronary Syndrome.

Valgimigli et al. · Circulation

Added to ASH registry: 2026-05-28

Design, expression and biological evaluation of DX-88mut as a novel selective factor XIa inhibitor for antithrombosis

Sun et al. · Bioorganic chemistry

Added to ASH registry: 2026-05-28

Development of a Medication-Use Evaluation Template for Andexanet Alfa in the Reversal of Anticoagulation With Factor Xa Inhibitors

Fera et al. · Journal of pharmacy practice

Added to ASH registry: 2026-05-28

Development of an Ultrasensitive Competitive Double-Enzyme Cascade Fluorescence Signal Amplification Method for Factor XIa Inhibitor Screening

Zhan et al. · Analytical chemistry

Added to ASH registry: 2026-05-28

Dilemmas in the diagnosis and management of antiphospholipid syndrome.

Manning et al. · Journal of thrombosis and haemostasis : JTH

Added to ASH registry: 2026-05-28

Direct Oral Anticoagulants in Budd-Chiari Syndrome.

Thapa et al. · European journal of haematology

Added to ASH registry: 2026-05-28

Direct-Acting Oral Anticoagulant Dabigatran as a Bridging Therapy while Optimizing Warfarin Dosage for Cardioembolic Stroke

Venketasubramanian et al. · Cerebrovascular diseases extra

Added to ASH registry: 2026-05-28

Discovery and Characterization of Panaxatriol as a Novel Thrombin Inhibitor from Panax notoginseng Using a Combination of Computational and Experimental Approaches

Wang et al. · Planta medica

Added to ASH registry: 2026-05-28

Discovery of a new lead molecule to develop a novel class of human factor XIIa inhibitors

Dumas et al. · Journal of thrombosis and thrombolysis

Added to ASH registry: 2026-05-28

Discovery of Highly Selective, Potent, Covalent, and Orally Bioavailable Factor XIIa Inhibitors for the Treatment of Thrombo-Inflammation

Meng et al. · Journal of medicinal chemistry

Added to ASH registry: 2026-05-28

Discovery of New Inhibitors of Human Activated Protein C to Treat Hemophilia

Aliter et al. · Letters in drug design & discovery

Added to ASH registry: 2026-05-28

Dual vs triple antithrombotic therapy in atrial fibrillation and acute coronary syndrome: An updated meta-analysis of randomized controlled trials.

Sainbayar et al. · Journal of investigative medicine : the official publication of the American Federation for Clinical Research

Added to ASH registry: 2026-05-28

Early Time Courses of Recurrent Venous Thromboembolism and Bleeding during Apixaban or Dalteparin Therapy for Patients with Cancer.

Cohen AT et al. · Thrombosis and haemostasis

Added to ASH registry: 2026-05-28

Edoxaban Antithrombotic Therapy for Atrial Fibrillation and Stable Coronary Artery Disease

Cho et al. · The New England journal of medicine

Added to ASH registry: 2026-05-28

Efanesoctocog alfa: the renaissance of Factor VIII replacement therapy.

Dargaud Y et al. · Haematologica

Added to ASH registry: 2026-05-28

Effect of Age, Sex, Renal Impairment and Hepatic Impairment on the Safety, Pharmacokinetics and Pharmacodynamics of Asundexian

Brase et al. · Clinical pharmacokinetics

Added to ASH registry: 2026-05-28

Effect of low- versus high-dose 4-factor prothrombin complex concentrate in factor Xa inhibitor-associated bleeding: A qualitative systematic review

Phillips et al. · American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists

Added to ASH registry: 2026-05-28

Efficacy and safety of antithrombotic therapy for preventing and treating pediatric thromboembolic disease: a systematic review.

Gao H et al. · Scientific reports

Added to ASH registry: 2026-05-28

Efficacy and safety of factor Xa inhibitors in low body weight patients

Tan et al. · Pharmacotherapy

Added to ASH registry: 2026-05-28

Efficacy and safety of rivaroxaban versus apixaban for venous thromboembolism: A systematic review and meta-analysis of observational studies

Fredman et al. · Journal of thrombosis and thrombolysis

Added to ASH registry: 2026-05-28

Efficacy and Safety of Systemic Thrombolysis and Catheter-Directed Therapy in Pulmonary Embolism: A Narrative Review.

Upadhyay H et al. · Cureus

Added to ASH registry: 2026-05-28

Efficacy of Infrared Thermographic Camera in Early Detection of Vascular Obstruction Following Microvascular Flaps in Head and Neck Reconstruction: A Prospective Clinical Study

Thyagaraj J et al. · Journal of maxillofacial and oral surgery

Added to ASH registry: 2026-05-28

Efficacy of Therapeutic Plasma Exchange or Cangrelor as an Adjunctive Strategy to Facilitate Cardiopulmonary Bypass in Patients with Heparin-Induced Thrombocytopenia: A Systematic Review and Meta-Analysis

Del et al. · Journal of cardiothoracic and vascular anesthesia

Added to ASH registry: 2026-05-28

Enoxaparin is not an oral factor Xa inhibitor. Response to Sutton et al. real-world clinical outcomes among US veterans with oral factor Xa inhibitor-related major bleeding treated with andexanet alfa or 4-factor prothrombin complex concentrate

Buka et al. · Journal of thrombosis and thrombolysis

Added to ASH registry: 2026-05-28

Evaluation and Management of Mechanical Heart Valve Dysfunction and Thrombosis.

Parizher et al. · Current cardiology reports

Added to ASH registry: 2026-05-28

Evaluation of Drug-Drug Interactions Between Clarithromycin and Direct Oral Anticoagulants Using Physiologically Based Pharmacokinetic Models.

Yang Z et al. · Pharmaceutics

Added to ASH registry: 2026-05-28

Evolution and advances in endovascular mechanical thrombectomy of cerebral venous sinus thrombosis.

Kan et al. · International journal of medical sciences

Added to ASH registry: 2026-05-28

Factor Xa Inhibitors versus warfarin in patients with morbid obesity and atrial fibrillation

Dobry et al. · European journal of clinical pharmacology

Added to ASH registry: 2026-05-28

Factor XI inhibition in hemodialysis patients: the safer anticoagulation?

Stamellou et al. · Kidney international

Added to ASH registry: 2026-05-28

Factor XI inhibitors - Rising stars in anti-thrombotic therapy?

Nolte. · Journal of the neurological sciences

Added to ASH registry: 2026-05-28

Factor XI/XIa inhibitors for the prevention and treatment of venous and arterial thromboembolism: A narrative review

Prakash et al. · Vascular medicine (London, England)

Added to ASH registry: 2026-05-28

Factor XIa inhibitors: collecting the clinical evidence

Lewis et al. · European heart journal. Cardiovascular pharmacotherapy

Added to ASH registry: 2026-05-28

Heparin-Calibrated Anti-Factor Xa Assay for the Measurement of Direct Anticoagulants such as Apixaban, Rivaroxaban, and Edoxaban

Ahn et al. · Clinical laboratory

Added to ASH registry: 2026-05-28

Higher incidence of venous thromboembolism associated with increasing lines of treatment in heavily treated ovarian cancer patients.

Lampert et al. · International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Added to ASH registry: 2026-05-28

How I treat pediatric venous thromboembolism in the DOAC era.

Bhat RV et al. · Blood

Added to ASH registry: 2026-05-28

How we manage a high D-dimer.

Franchini et al. · Haematologica

Added to ASH registry: 2026-05-28

Idarucizumab in dabigatran-treated patients with acute stroke: a review and clinical update.

Frol et al. · Frontiers in neurology

Added to ASH registry: 2026-05-28

Identification and anticoagulant mechanisms of novel factor XIa inhibitory peptides by virtual screening of a in silico generated deep-sea peptide database

Ouyang et al. · Food research international (Ottawa, Ont.)

Added to ASH registry: 2026-05-28

Identification, screening, and comprehensive evaluation of novel thrombin inhibitory peptides from the hirudo produced using pepsin

Chai X et al. · Frontiers in pharmacology

Added to ASH registry: 2026-05-28

Immune-stealth VP28-conjugated heparin nanoparticles for enhanced and reversible anticoagulation.

Hussein et al. · Nanotechnology

Added to ASH registry: 2026-05-28

Impact of Bivalirudin on Ischemia/Reperfusion Injury in Patients with Reperfused STEMI Assessed by Cardiac Magnetic Resonance

Zhang et al. · Pharmaceuticals (Basel, Switzerland)

Added to ASH registry: 2026-05-28

Impact of elevated direct factor Xa inhibitor plasma levels on perioperative blood loss in patients undergoing urgent surgery

Mair et al. · Transfusion

Added to ASH registry: 2026-05-28

Incidence and risk factors of VTE in lung cancer: a meta-analysis.

Yang et al. · Annals of medicine

Added to ASH registry: 2026-05-28

Incidence of venous thromboembolism after cardiovascular surgery.

Saitoh et al. · Asian cardiovascular & thoracic annals

Added to ASH registry: 2026-05-28

Incidence of venous thromboembolism in pediatric orthopedics: A systematic review.

Boulet et al. · Orthopaedics & traumatology, surgery & research : OTSR

Added to ASH registry: 2026-05-28

Integrated microfluidic multiple electrode aggregometry for point-of-care platelet function analysis.

Zhao et al. · Lab on a chip

Added to ASH registry: 2026-05-28

Intravenous thrombolysis and mechanical thrombectomy in acute stroke patients on direct oral anticoagulants.

Kristoffersen et al. · Journal of neurology

Added to ASH registry: 2026-05-28

Investigating Protein-Nucleic Acid Binding Interactions with Diethylpyrocarbonate Covalent Labeling-Mass Spectrometry.

Kirsch ZJ et al. · Journal of the American Society for Mass Spectrometry

Added to ASH registry: 2026-05-28

Is bivalirudin ready for a comeback? Pros and cons.

Stone GW et al. · EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology

Added to ASH registry: 2026-05-28

Is there a role for the laboratory monitoring in the management of specific antidotes of direct oral anticoagulants?.

Gendron et al. · Thrombosis research

Added to ASH registry: 2026-05-28

Laboratory Evaluation of Interferences Associated with Factor XIa Inhibitors Asundexian and Milvexian in Routine Coagulation Assays

Buckley et al. · Diagnostics (Basel, Switzerland)

Added to ASH registry: 2026-05-28

Latest advances in the reversal strategies for direct oral anticoagulants.

Escal et al. · Fundamental & clinical pharmacology

Added to ASH registry: 2026-05-28

Lentiviral Gene Therapy with CD34+ Hematopoietic Cells for Hemophilia A.

Srivastava A et al. · The New England journal of medicine

Added to ASH registry: 2026-05-28

Letter to the editor: 1-year clinical outcomes of bivalirudin vs. unfractionated heparin in patients with type 2 diabetes undergoing elective percutaneous coronary intervention.

Rajab F et al. · European heart journal. Cardiovascular pharmacotherapy

Added to ASH registry: 2026-05-28

Light transmission aggregometry for platelet function testing: position paper on current recommendations and French proposals for accreditation.

Stépanian et al. · Platelets

Added to ASH registry: 2026-05-28

Lupus anticoagulant and valvular cardiac surgery

Kamath et al. · Perfusion

Added to ASH registry: 2026-05-28

Macrocyclic Inhibitors Targeting the Prime Site of the Fibrinolytic Serine Protease Plasmin

Wiedemeyer et al. · ChemMedChem

Added to ASH registry: 2026-05-28

Management of direct oral anticoagulant drug interactions in hospitalized patients.

Al Zaria MH et al. · Journal of thrombosis and thrombolysis

Added to ASH registry: 2026-05-28

Management of Neonatal Aortic Thrombosis: Challenges and Outcomes With Systemic and Intra-arterial Thrombolysis.

Reddy et al. · Cureus

Added to ASH registry: 2026-05-28

Management options for pediatric venous thromboembolic disease: Beyond anticoagulation with endovascular therapies.

Mitta et al. · Thrombosis research

Added to ASH registry: 2026-05-28

Mechanical Thrombectomy in Anticoagulated Patients With Acute Ischemic Stroke: A Meta-Analysis.

Zhang et al. · The neurologist

Added to ASH registry: 2026-05-28

Met343Val mutation disrupts the shuttling of Trp380 leading to a low-activity conformer of activated protein C and causes thrombosis.

Zhou et al. · Journal of thrombosis and haemostasis : JTH

Added to ASH registry: 2026-05-28

Milvexian vs apixaban for stroke prevention in atrial fibrillation: The LIBREXIA atrial fibrillation trial rationale and design

Jain et al. · American heart journal

Added to ASH registry: 2026-05-28

Milvexian, a novel factor XIa inhibitor for stroke prevention: pharmacokinetic and pharmacodynamic evaluation

Mar et al. · Expert opinion on drug metabolism & toxicology

Added to ASH registry: 2026-05-28

Milvexian: An Oral, Bioavailable Factor XIa Inhibitor

Parsa et al. · Cardiology and therapy

Added to ASH registry: 2026-05-28

Milvexian: evaluating the factor XIa inhibitor for the treatment of acute coronary syndrome

Tantry et al. · Expert opinion on pharmacotherapy

Added to ASH registry: 2026-05-28

Molecular Epidemiological Characteristics of Carbapenem Resistantfrom Hospital Wastewater.

Zhang Q et al. · Infection and drug resistance

Added to ASH registry: 2026-05-28

Multidrug-Resistant Bacteria in Aquaculture Systems in Accra, Ghana

Dayie et al. · Environmental health insights

Added to ASH registry: 2026-05-28

Obstetric antiphospholipid syndrome.

Soto-Peleteiro et al. · Medicina clinica

Added to ASH registry: 2026-05-28

OCEANIC-AF and the inferior efficacy of asundexian compared to apixaban in patients at high risk with atrial fibrillation: Have we come to the end of the road for factor XIa inhibitors?

Ferdinand et al. · American heart journal plus : cardiology research and practice

Added to ASH registry: 2026-05-28

Optimization of laboratory diagnosis of heparin-induced thrombocytopenia using HemosIL-AcuStar-HIT-IgG assay.

Tucker et al. · Laboratory medicine

Added to ASH registry: 2026-05-28

Performance evaluation of heparin-induced platelet aggregation vs serotonin release assay.

Barouqa et al. · American journal of clinical pathology

Added to ASH registry: 2026-05-28

Perioperative Management of Patients Taking Direct Oral Anticoagulants: A Review.

Douketis et al. · JAMA

Added to ASH registry: 2026-05-28

Pharmacokinetics and pharmacodynamics of drug‒drug interactions in hospitalized older adults treated with direct oral anticoagulants.

Decaix T et al. · Aging clinical and experimental research

Added to ASH registry: 2026-05-28

Pharmacokinetics and pharmacodynamics of the factor XIa-inhibiting antibody osocimab in healthy male East Asian volunteers: Results from two phase 1 studies

Dong et al. · Pharmacology research & perspectives

Added to ASH registry: 2026-05-28

Pharmacokinetics of asundexian with combined CYP3A and P-gp inhibitors and an inducer: Target in vitro and in vivo studies

Kanefendt et al. · British journal of clinical pharmacology

Added to ASH registry: 2026-05-28

Pharmacokinetics, pharmacodynamics, and safety of asundexian in healthy Chinese and Japanese volunteers, and comparison with Caucasian data

Chen et al. · Clinical and translational science

Added to ASH registry: 2026-05-28

Pharmacokinetics, pharmacodynamics, and safety of fesomersen, a novel antisense inhibitor of factor XI, in healthy Chinese, Japanese, and Caucasian volunteers

Liu et al. · Clinical and translational science

Added to ASH registry: 2026-05-28

Prevention of Stroke in Intracerebral Haemorrhage Survivors with Atrial Fibrillation: Rationale and Design for PRESTIGE-AF Trial.

Korompoki et al. · Thrombosis and haemostasis

Added to ASH registry: 2026-05-28

Prothrombin complex concentrate for direct factor Xa inhibitor-associated bleeding or before urgent surgery

Shaw et al. · Thrombosis research

Added to ASH registry: 2026-05-28

Quantifying Residual Rivaroxaban Plasma Concentration after Antagonization with Andexanet Alfa: A Difficult Task in Routine Clinical Practice

Mair et al. · Hamostaseologie

Added to ASH registry: 2026-05-28

Real-world experience with edoxaban for anticoagulation in children at risk for coronary artery thrombosis

Sagiv et al. · Cardiology in the young

Added to ASH registry: 2026-05-28

Reevaluating the role of heparin during mechanical thrombectomy for acute ischemic stroke: Increased risks without functional benefit.

Jazayeri et al. · Clinical neurology and neurosurgery

Added to ASH registry: 2026-05-28

Reversal and resumption of anticoagulants in patients with anticoagulant-associated intracerebral hemorrhage.

Yang et al. · European journal of medical research

Added to ASH registry: 2026-05-28

Reversal of direct oral anticoagulants: guidance from the SSC of the ISTH.

Levy et al. · Journal of thrombosis and haemostasis : JTH

Added to ASH registry: 2026-05-28

Rivaroxaban for stroke patients with antiphospholipid syndrome (RISAPS): protocol for a randomized controlled, phase IIb proof-of-principle trial.

Mittal P et al. · Research and practice in thrombosis and haemostasis

Added to ASH registry: 2026-05-28

Rivaroxaban for Venous Thrombosis in a Patient with Congenital Antithrombin Deficiency

Takeuchi et al. · International heart journal

Added to ASH registry: 2026-05-28

Safety and efficacy of factor XIa inhibition with milvexian for secondary stroke prevention (AXIOMATIC-SSP): a phase 2, international, randomised, double-blind, placebo-controlled, dose-finding trial

Sharma et al. · The Lancet. Neurology

Added to ASH registry: 2026-05-28

Safety profile of drugs used in non-cystic fibrosis bronchiectasis: a narrative review

Upadhyay et al. · Therapeutic advances in drug safety

Added to ASH registry: 2026-05-28

Safety, tolerability, pharmacokinetics and pharmacodynamics of milvexian with aspirin and/or clopidogrel in healthy participants

Perera et al. · Scientific reports

Added to ASH registry: 2026-05-28

Scaling theory of fibrin polymerization.

Panyukov · Physical review. E

Added to ASH registry: 2026-05-28

Selective factor XI/XIa inhibitors: a beacon of hope in anticoagulation therapy

Xie et al. · Future medicinal chemistry

Added to ASH registry: 2026-05-28

Sepsis-induced coagulopathy (SIC) in the management of sepsis.

Iba et al. · Annals of intensive care

Added to ASH registry: 2026-05-28

Sepsis-Induced Coagulopathy: A Comprehensive Narrative Review of Pathophysiology, Clinical Presentation, Diagnosis, and Management Strategies.

Williams et al. · Anesthesia and analgesia

Added to ASH registry: 2026-05-28

Short term outcome of neonatal venous thromboembolism in anticoagulated versus observed patients.

Beg KA et al. · Thrombosis research

Added to ASH registry: 2026-05-28

Splanchnic vein thrombosis: management for the thrombosis specialist.

Barnum et al. · Journal of thrombosis and haemostasis : JTH

Added to ASH registry: 2026-05-28

Stroke Prevention in Atrial Fibrillation: Our Current Failures and Required Research

Gurol et al. · Stroke

Added to ASH registry: 2026-05-28

Tackling a deadly global phenomenon: sepsis induced coagulopathy: A narrative review.

Arshad et al. · JPMA. The Journal of the Pakistan Medical Association

Added to ASH registry: 2026-05-28

Targeting tissue factor pathway inhibitor with concizumab to improve hemostasis in patients with Glanzmann thrombasthenia: an in vitro study.

Dubut et al. · Journal of thrombosis and haemostasis : JTH

Added to ASH registry: 2026-05-28

Tenecteplase versus alteplase for acute stroke within 4·5 h of onset (ATTEST-2): a randomised, parallel group, open-label trial.

Muir KW et al. · The Lancet. Neurology

Added to ASH registry: 2026-05-28

Tenecteplase vs Alteplase for Patients With Acute Ischemic Stroke: The ORIGINAL Randomized Clinical Trial.

Meng X et al. · JAMA

Added to ASH registry: 2026-05-28

The changing face of cerebral venous sinus thrombosis-emerging new causes and treatments.

Dix et al. · Journal of thrombosis and haemostasis : JTH

Added to ASH registry: 2026-05-28

The effect of hypotonic pharmacologic lipodissolution on abdominal free flap perfusion: a case report

Seo et al. · Gland surgery

Added to ASH registry: 2026-05-28

The efficacy and safety of direct oral anticoagulants in the treatment of the acute phase of heparin-induced thrombocytopenia: A systematic review.

Sadowski et al. · American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists

Added to ASH registry: 2026-05-28

The factor XI/XIa antibody abelacimab combined with enoxaparin inhibits filter clotting in hemodialysis circuits ex vivo

Grafeneder et al. · Journal of thrombosis and thrombolysis

Added to ASH registry: 2026-05-28

The impact of OCEANIC-AF and the future of factor XIa inhibitors

Palaiodimou et al. · Med (New York, N.Y.)

Added to ASH registry: 2026-05-28

The management of splanchnic vein thrombosis in acute pancreatitis: a global DELPHI consensus study.

Scott et al. · HPB : the official journal of the International Hepato Pancreato Biliary Association

Added to ASH registry: 2026-05-28

The pharmacokinetics of dabigatran in a rat model of hyperlipidaemia induced by poloxamer 407

Kim et al. · Xenobiotica; the fate of foreign compounds in biological systems

Added to ASH registry: 2026-05-28

The Post-Left Atrial Appendage Occlusion Antithrombotic Selection Conundrum: Are We There Yet?

Katapadi A et al. · Journal of the American College of Cardiology

Added to ASH registry: 2026-05-28

The third-generation anticoagulants: factors XI, XII, and XIII inhibitors

Prajapathi et al. · The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology

Added to ASH registry: 2026-05-28

The Use of Apixaban for Postoperative Venous Thromboembolism Prophylaxis in Gynecologic Cancer

Knisely et al. · Annals of surgical oncology

Added to ASH registry: 2026-05-28

Therapeutic Potential of FXI Inhibitors: Hype or Hope?

Galli et al. · Drugs

Added to ASH registry: 2026-05-28

Thrombotic antiphospholipid syndrome: From guidelines to clinical management.

Paredes-Ruiz et al. · Medicina clinica

Added to ASH registry: 2026-05-28

Ticagrelor vs clopidogrel when coadministered with bivalirudin in patients with acute coronary syndrome undergoing percutaneous coronary intervention

Li et al. · Research and practice in thrombosis and haemostasis

Added to ASH registry: 2026-05-28

Treatment of Cutaneous Leishmaniasis lesion caused by Leishmania major Using Leech Therapy in BALB/c Mice.

Shirani-Bidabadi · Journal of vector borne diseases

Added to ASH registry: 2026-05-28

Type 2N von Willebrand disease: genotype drives different bleeding phenotypes and treatment needs.

Daniel MY et al. · Journal of thrombosis and haemostasis : JTH

Added to ASH registry: 2026-05-28

Use of Andexanet Alfa for Factor Xa Inhibitor Reversal in US Verified Trauma Centers: A National Survey.

Fasanya et al. · Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis

Added to ASH registry: 2026-05-28

Use of protease substrate specificity screening in the rational design of selective protease inhibitors with unnatural amino acids: Application to HGFA, matriptase, and hepsin.

Mahoney MW et al. · Protein science : a publication of the Protein Society

Added to ASH registry: 2026-05-28

When Direct Oral Anticoagulants Should Not Be Standard Treatment: JACC State-of-the-Art Review.

Bejjani et al. · Journal of the American College of Cardiology

Added to ASH registry: 2026-05-28

A Bioinspired and Cost-Effective Device for Minimally Invasive Blood Sampling

Zoratto N et al. · Advanced science

Added to ASH registry: 2026-05-27

A reevaluation and redescription of the branchiobdellidan Sathodrilus tetrodonta (Pierantoni, 1906) new comb. (Annelida: Clitellata)

Gelder SR · Zootaxa

Added to ASH registry: 2026-05-27

Anticoagulation Monitoring and Targets: The Pediatric Extracorporeal Membrane Oxygenation Anticoagulation Collaborative Consensus Conference

Ozment CP et al. · Pediatric critical care medicine

Added to ASH registry: 2026-05-27

Antithrombotic therapy in patients with complex percutaneous coronary intervention

Larrubia Valle et al. · Interventional cardiology clinics

Added to ASH registry: 2026-05-27

Aptameric hirudins as selective and reversible EXosite-ACTive site (EXACT) inhibitors

Yu HC et al. · Nature communications

Added to ASH registry: 2026-05-27

Biology, morphology and taxonomy of a snail-feeding leech from North Carolina USA, provisionally identified as Helobdella lineata (Verrill, 1874) (Glossiphoniidae): First evidence for extra-oral digestion in the Hirudinea

Sawyer RT et al. · Zootaxa

Added to ASH registry: 2026-05-27

Biomimetic nanoparticles co-deliver hirudin and lumbrukinase to ameliorate thrombus and inflammation for atherosclerosis therapy

Cheng M et al. · Asian journal of pharmaceutical sciences

Added to ASH registry: 2026-05-27

Bivalirudin as a substitute for heparin in neurointervention for patients with heparin-induced thrombocytopenia

Sukumaran M et al. · Journal of stroke and cerebrovascular diseases

Added to ASH registry: 2026-05-27

Bivalirudin as an anticoagulation strategy for acute hemodialysis in children: Two cases with a summary of recent literature

Viaene LV et al. · Hemodialysis international

Added to ASH registry: 2026-05-27

Bivalirudin in Extracorporeal Membrane Oxygenation

Dunham S et al. · Journal of cardiovascular pharmacology

Added to ASH registry: 2026-05-27

Bivalirudin Monitoring in Pediatric Ventricular Assist Device and Extracorporeal Membrane Oxygenation: Analysis of Single-Center Retrospective Cohort Data 2018-2022

Engel ER et al. · Pediatric Critical Care Medicine

Added to ASH registry: 2026-05-27

Bivalirudin versus heparin in patients with or without bail-out GPI use: a pre-specified subgroup analysis

Liao et al. · BMC medicine

Added to ASH registry: 2026-05-27

Bivalirudin versus heparin in ST and non-ST-segment elevation myocardial infarction

Omerovic et al. · Cardiovascular revascularization medicine

Added to ASH registry: 2026-05-27

Bivalirudin versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention

Sun B et al. · Cardiovascular drugs and therapy

Added to ASH registry: 2026-05-27

Bivalirudin vs heparin anticoagulation in STEMI: confirmation of the BRIGHT-4 results

Stone GW · Journal of the American College of Cardiology

Added to ASH registry: 2026-05-27

Bolus-only bivalirudin for carotid endarterectomy in a patient with heparin-induced thrombocytopenia

Venema R et al. · Canadian journal of anaesthesia

Added to ASH registry: 2026-05-27

Characterization of active peptides derived from three leeches and comparison of their anti-thrombotic mechanisms using the tail vein thrombosis model in mice and metabonomics

Dong Y et al. · Frontiers in pharmacology

Added to ASH registry: 2026-05-27

Combined drug anti-deep vein thrombosis therapy based on platelet membrane biomimetic targeting nanotechnology

Xiao H et al. · Biomaterials

Added to ASH registry: 2026-05-27

Comparison of Outcomes in Patients Requiring Mechanical Circulatory Support Who Received Cangrelor in Addition to Anticoagulation Versus Anticoagulation Alone

Martin TC et al. · Journal of cardiothoracic and vascular anesthesia

Added to ASH registry: 2026-05-27

Comparison of short-to-medium-term ischemia and bleeding risks between unfractionated heparin and bivalirudin

Hou et al. · Zhonghua yi xue za zhi

Added to ASH registry: 2026-05-27

Comparison of the effects on coagulation function and safety of bivalirudin and heparin

Wang et al. · Medicine

Added to ASH registry: 2026-05-27

Differential use of glycoprotein IIb/IIIa inhibitors with bivalirudin in patients with STEMI undergoing PCI

Mushahid H et al. · American journal of cardiovascular drugs

Added to ASH registry: 2026-05-27

Efficacy and potential mechanism of atherosclerosis prevention by the active components of leech based on network pharmacology

Lv Q et al. · Heliyon

Added to ASH registry: 2026-05-27

Evaluation of hemostatic, anti-inflammatory, wound healing, skin irritation and acute toxicity of leech (Hirudo nipponia) extract

Li et al. · Journal of ethnopharmacology

Added to ASH registry: 2026-05-27

Evolution of treatment for unspecific back pain: From past to future

Herrera B et al. · La Tunisie medicale

Added to ASH registry: 2026-05-27

Heparin and bivalirudin in percutaneous coronary intervention for acute coronary syndrome

Wang et al. · Cardiovascular therapeutics

Added to ASH registry: 2026-05-27

Heparin-induced DRESS syndrome in a paediatric patient and successful anaesthetic management in cardiovascular bypass surgery: case report

Pea-Blanco L et al. · Journal of cardiothoracic surgery

Added to ASH registry: 2026-05-27

Hirudin delays the progression of diabetic kidney disease by inhibiting glomerular endothelial cell migration and abnormal angiogenesis

Zhang J et al. · Biomedicine & pharmacotherapy

Added to ASH registry: 2026-05-27

Hirudin in the Treatment of Chronic Kidney Disease

Liu SJ et al. · Molecules

Added to ASH registry: 2026-05-27

Impact of inflammation and steroids on anti-coagulation in children supported on a ventricular assist device

Brandewie K et al. · Journal of Artificial Organs

Added to ASH registry: 2026-05-27

Improving Mechanical Circulatory Support Outcomes in Failing Bidirectional Glenn Physiology

Kobayashi RL et al. · Pediatric Cardiology

Added to ASH registry: 2026-05-27

Intravenous Direct Thrombin Inhibitors for Acute Venous Thromboembolism or Heparin-Induced Thrombocytopenia with Thrombosis in Children: A Systematic Review

Kiskaddon AL et al. · Seminars in Thrombosis and Hemostasis

Added to ASH registry: 2026-05-27

Intravenous Direct Thrombin Inhibitors for Acute Venous Thromboembolism or Heparin-Induced Thrombocytopenia with Thrombosis in Children: A Systematic Review of the Literature

Kiskaddon AL et al. · Semin Thromb Hemost

Added to ASH registry: 2026-05-27

Leech extract alleviates idiopathic pulmonary fibrosis by TGF-β1/Smad3 signaling pathway

Zhang Y et al. · Journal of ethnopharmacology

Added to ASH registry: 2026-05-27

Monitoring Breast Reconstruction Flaps Using Near-Infrared Spectroscopy Tissue Oximetry

Kumbasar DE et al. · Plastic surgical nursing : official journal of the American Society of Plastic and Reconstructive Surgical Nurses

Added to ASH registry: 2026-05-27

New anticoagulant protein from medicinal leech

Manuvera VA et al. · Biochemical and biophysical research communications

Added to ASH registry: 2026-05-27

Optimizing outcomes in ST-segment elevation myocardial infarction: is prolonged bivalirudin infusion the answer?

Cavender et al. · Journal of the American College of Cardiology

Added to ASH registry: 2026-05-27

Postprocedural anticoagulation after primary percutaneous coronary intervention for ST-segment-elevation myocardial infarction with bivalirudin

Yan et al. · Circulation

Added to ASH registry: 2026-05-27

Prospective randomized pilot study comparing bivalirudin versus heparin in neonatal and pediatric extracorporeal membrane oxygenation

McMichael A et al. · Pediatric critical care medicine

Added to ASH registry: 2026-05-27

Recombinant hirudin attenuates pulmonary hypertension and thrombosis in acute pulmonary embolism rat model

Wei X et al. · PeerJ

Added to ASH registry: 2026-05-27

Recombinant hirudin suppresses angiogenesis of diffuselarge B-cell lymphoma through regulation of the PAR-1-VEGF

Zhao J et al. · Chemical biology & drug design

Added to ASH registry: 2026-05-27

Recombinant neorudin and its active metabolite hirudin: the fate of a novel anticoagulant drug

Li Q et al. · Frontiers in pharmacology

Added to ASH registry: 2026-05-27

Reduced-dose of bivalirudin (without the post-procedure infusion) in patients with acute coronary syndrome undergoing elective percutaneous coronary intervention

Wang Q et al. · BMC cardiovascular disorders

Added to ASH registry: 2026-05-27

Research progress on the treatment of diabetic nephropathy with leech and its active ingredients

Tian F et al. · Frontiers in endocrinology

Added to ASH registry: 2026-05-27

Revisiting the effect of cholesteryl sulfate on clotting and fibrinolysis: Inhibition of human thrombin and other human blood proteases

Al-Horani RA · Heliyon

Added to ASH registry: 2026-05-27

Revisiting the efficacy and safety of bivalirudin in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention

Maqsood MH et al. · Catheterization and cardiovascular interventions

Added to ASH registry: 2026-05-27

Risk factors for thromboembolic events in pediatric patients with ventricular assist devices

Adderley J et al. · JTCVS open

Added to ASH registry: 2026-05-27

Risk factors for thromboembolic events in pediatric patients with ventricular assist devices

Adderley J et al. · JTCVS Open

Added to ASH registry: 2026-05-27

Safety, tolerability, pharmacodynamics, and pharmacokinetics of recombinant Neorudin, a new anticoagulant drug, in patients undergoing coronary angiography

Liu YB et al. · Clinical pharmacology in drug development

Added to ASH registry: 2026-05-27

The effect and mechanism of freeze-dried powder ofon improving inflammatory injury of rat glomerular mesangial cells through TXNIP / NLRP3 pathway

Sun X et al. · Heliyon

Added to ASH registry: 2026-05-27

Therapeutic Potentials of Medicinal Leech in Chinese Medicine

Wu S et al. · American Journal of Chinese Medicine

Added to ASH registry: 2026-05-27

Vasospastic angina: a review on diagnostic approach and management

Jenkins et al. · Therapeutic advances in cardiovascular disease

Added to ASH registry: 2026-05-27

Leech protein extract ameliorated hyperuricemia by restoring gut microbiota dysregulation and affecting serum metabolites

Liu X, Liang XQ, Lu TC et al. · World journal of gastroenterology

Added to ASH registry: 2026-05-26

The High-Affinity Chymotrypsin Inhibitor Eglin C Poorly Inhibits Human Chymotrypsin-Like Protease: Gln192 and Lys218 Are Key Determinants

Németh BZ, Kiss B, Sahin-Tóth M, Magyar C, Pál G · Proteins

Added to ASH registry: 2026-05-26

Hirudin enhances perforator flap survival: Clinical application report and mechanistic exploration

Wei D et al. · Journal of stomatology, oral and maxillofacial surgery

Added to ASH registry: 2026-03-18

Investigation of oxidant-antioxidant status in patients treated with hirudotherapy: an experimental study

Sarikan I, Savas H · JPMA. The Journal of the Pakistan Medical Association

Added to ASH registry: 2026-03-18

New anticoagulant protein from medicinal leech

Manuvera V et al. · Biochemical and biophysical research communications

Added to ASH registry: 2026-03-18

Therapeutic Potentials of Medicinal Leech in Chinese Medicine

Wu S et al. · The American journal of Chinese medicine

Added to ASH registry: 2026-03-18

Transcriptomic profiling and the first spatial expression analysis of candidate genes in the salivary gland of the East Asian medicinal leech, Hirudo nipponia

Kim J et al. · Developmental and comparative immunology

Added to ASH registry: 2026-03-18

Tyrosine phosphorylation of recombinant hirudin increases affinity to thrombin and antithrombotic activity

Volkova A, Semenyuk P · Proteins

Added to ASH registry: 2026-03-18

A BRIGHT outlook for bivalirudin in patients with ST-segment elevation myocardial infarction

Vergallo et al. · European heart journal

Added to ASH registry: 2026-05-29

Analysis of Wholesale Drug Acquisition and Laboratory Assessment Costs Between Heparin Compared With Bivalirudin-Based Systemic Anticoagulation Strategies in Adult Extracorporeal Membrane Oxygenation

Seelhammer et al. · Critical care medicine

Added to ASH registry: 2026-05-29

Anti-thrombotic Therapy With Cangrelor and Bivalirudin in Venoarterial Extracorporeal Membrane Oxygenation Patients Undergoing Percutaneous Coronary Intervention: A Single-Center Experience

Baldetti et al. · ASAIO journal (American Society for Artificial Internal Organs : 1992)

Added to ASH registry: 2026-05-29

Anticoagulation Stability With Bivalirudin: Positioning the Horse Before the Cart

Chen et al. · ASAIO journal (American Society for Artificial Internal Organs : 1992)

Added to ASH registry: 2026-05-29

Apixaban at Apex? Aligning Drug Pricing With Value in Cancer-Associated Thrombosis

Ito et al. · Annals of internal medicine

Added to ASH registry: 2026-05-29

Bivalirudin Compared to Heparin as the Primary Anticoagulant in Pediatric Berlin Heart Recipients

Freniere et al. · ASAIO journal (American Society for Artificial Internal Organs : 1992)

Added to ASH registry: 2026-05-29

Bivalirudin Superiority in Pediatric Berlin Hearts: Too Early to Draw Conclusions?

Seelhammer et al. · ASAIO journal (American Society for Artificial Internal Organs : 1992)

Added to ASH registry: 2026-05-29

Comparison of bivalirudin versus heparin in adult extracorporeal membrane oxygenation anticoagulant therapy: A retrospective case-control study

Tong et al. · The International journal of artificial organs

Added to ASH registry: 2026-05-29

Editorial: Bivalirudin with post-procedural infusion: Should the Guidelines change to keep up with the data?

Lipinski · Cardiovascular revascularization medicine : including molecular interventions

Added to ASH registry: 2026-05-29

Functionalization of PCL-based nanofibers loaded with hirudin as blood contact materials

Zheng et al. · Biomaterials advances

Added to ASH registry: 2026-05-29

Impact of Bivalirudin on Patients with Acute Coronary Syndrome Undergoing Rotational Atherectomy in Real-Life Setting: A Retrospective Cohort Study

Li et al. · Anatolian journal of cardiology

Added to ASH registry: 2026-05-29

One-year clinical outcomes of bivalirudin versus unfractionated heparin in patients with type 2 diabetes undergoing elective percutaneous coronary intervention

Li et al. · Diabetes & metabolic syndrome

Added to ASH registry: 2026-05-29

One-Year Safety and Effectiveness of Bivalirudin versus Heparin in Patients Undergoing Elective Percutaneous Coronary Intervention

Li et al. · Reviews in cardiovascular medicine

Added to ASH registry: 2026-05-29

Pharmacokinetic drug-drug interactions with direct anticoagulants in the management of cancer-associated thrombosis

Van et al. · British journal of clinical pharmacology

Added to ASH registry: 2026-05-29

The effect of bivalirudin on coagulation function in male patients with coronary heart disease undergoing percutaneous coronary intervention

Dequan et al. · Pakistan journal of pharmaceutical sciences

Added to ASH registry: 2026-05-29

Use of Bivalirudin for Chronic Total Occlusion Percutaneous Intervention: Insights From the PROGRESS-CTO Registry

Verreault-Julien et al. · The Journal of invasive cardiology

Added to ASH registry: 2026-05-29

Use of ecarin chromogenic assay during bivalirudin anticoagulation in adult extracorporeal membrane oxygenation

Krauter et al. · Thrombosis research

Added to ASH registry: 2026-05-29

30-Day Post-Discharge Prophylaxis with Rivaroxaban Prevents Porto-mesenteric Venous Thrombosis Following Laparoscopic Sleeve Gastrectomy

Swartz et al. · Obesity surgery

Added to ASH registry: 2026-05-28

6-(Arylaminomethyl) Isoquinolines as Enzyme Inhibitors and Their Preparation: A Patent Highlight of Factor XIIa Inhibitors

Al-Horani et al. · Cardiovascular & hematological agents in medicinal chemistry

Added to ASH registry: 2026-05-28

A bispecific antibody NXT007 exerts a hemostatic activity in hemophilia A monkeys enough to keep a nonhemophilic state.

Teranishi-Ikawa Y et al. · Journal of thrombosis and haemostasis : JTH

Added to ASH registry: 2026-05-28

A bispecific inhibitor of complement and coagulation blocks activation in complementopathy models via a novel mechanism

Andersen et al. · Blood

Added to ASH registry: 2026-05-28

A global comparative field study to evaluate the factor VIII activity of efanesoctocog alfa by one-stage clotting and chromogenic substrate assays at clinical haemostasis laboratories.

Pipe et al. · Haemophilia : the official journal of the World Federation of Hemophilia

Added to ASH registry: 2026-05-28

A new strategy for anticoagulation: The factor XI inhibitors

Vedovati et al. · European journal of internal medicine

Added to ASH registry: 2026-05-28

A Non-competitive Serpin-Like Thrombin Inhibitor Isolated from Moringa oleifera Exhibit a High Affinity for Thrombin

Sawetaji et al. · The protein journal

Added to ASH registry: 2026-05-28

A Retrospective Review of Four-Factor Prothrombin Complex Concentrate for Factor Xa Inhibitor-Related Bleedings

Hitchcock et al. · Journal of pharmacy practice

Added to ASH registry: 2026-05-28

Abelacimab in Cancer-Associated Thrombosis: The Right Drug at the Right Time for the Right Purpose. A Comprehensive Review.

Fioretti AM et al. · Reviews in cardiovascular medicine

Added to ASH registry: 2026-05-28

Acute pulmonary embolism: Diagnosis and management.

Khandait et al. · Indian heart journal

Added to ASH registry: 2026-05-28

Adherence to protocols for the use of reversal agents in patients treated with direct oral anticoagulants

Mitrovic et al. · Current medical research and opinion

Added to ASH registry: 2026-05-28

Adjunctive technologies in postoperative free-flap monitoring: a systematic review

Lacey H et al. · Journal of plastic, reconstructive & aesthetic surgery : JPRAS

Added to ASH registry: 2026-05-28

Anticoagulant therapies against sepsis-induced disseminated intravascular coagulation.

Umemura et al. · Acute medicine & surgery

Added to ASH registry: 2026-05-28

Anticoagulation with Edoxaban in Patients with Atrial High-Rate Episodes

Hsu et al. · The New England journal of medicine

Added to ASH registry: 2026-05-28

Anticoagulation with Edoxaban in Patients with Atrial High-Rate Episodes

Adabag et al. · The New England journal of medicine

Added to ASH registry: 2026-05-28

Anticoagulation with Edoxaban in Patients with Atrial High-Rate Episodes. Reply

Kirchhof et al. · The New England journal of medicine

Added to ASH registry: 2026-05-28

Antiphospholipid syndrome management: a 2023 update and practical algorithm-based approach.

Ambati et al. · Current opinion in rheumatology

Added to ASH registry: 2026-05-28

Antiphospholipid syndrome, antiphospholipid antibodies, and stroke.

Mittal et al. · International journal of stroke : official journal of the International Stroke Society

Added to ASH registry: 2026-05-28

Antiphospholipid syndrome: advances in diagnosis, pathogenesis, and management.

Knight et al. · BMJ (Clinical research ed.)

Added to ASH registry: 2026-05-28

Antithrombotic Effects of the Novel Small-Molecule Factor XIa Inhibitor Milvexian in a Rabbit Arteriovenous Shunt Model of Venous Thrombosis

Wang et al. · TH open : companion journal to thrombosis and haemostasis

Added to ASH registry: 2026-05-28

Apixaban and Rivaroxaban Anti-Xa Concentration Utilization in Clinical Practice

Kim et al. · Journal of cardiovascular pharmacology

Added to ASH registry: 2026-05-28

Apixaban for Prevention of Thromboembolism in Pediatric Heart Disease.

Payne et al. · Journal of the American College of Cardiology

Added to ASH registry: 2026-05-28

Apixaban for Treatment of Atrial Fibrillation and Venous Thromboembolism After Lung Transplantation

Nikodem et al. · Progress in transplantation (Aliso Viejo, Calif.)

Added to ASH registry: 2026-05-28

Apixaban versus no anticoagulation for the prevention of venous thromboembolism in children with newly diagnosed acute lymphoblastic leukaemia or lymphoma (PREVAPIX-ALL): a phase 3, open-label, randomised, controlled trial.

O'Brien et al. · The Lancet. Haematology

Added to ASH registry: 2026-05-28

Aptamer-thrombin loaded magnetic microspheres for bio-specific extraction and precise detection of hirudin

Cao X et al. · Talanta

Added to ASH registry: 2026-05-28

Assays to Monitor Bivalirudin

Davidson. · Methods in molecular biology (Clifton, N.J.)

Added to ASH registry: 2026-05-28

Assessment of Platelet Function by Automated Light Transmission Aggregometry.

Sarkar et al. · Methods in molecular biology (Clifton, N.J.)

Added to ASH registry: 2026-05-28

Assessment of Platelet Function by High-Throughput Screening Light Transmission Aggregometry: Optimul Assay.

Chan et al. · Methods in molecular biology (Clifton, N.J.)

Added to ASH registry: 2026-05-28

Autoimmune Heparin-Induced Thrombocytopenia

Warkentin TE · Journal of clinical medicine

Added to ASH registry: 2026-05-28

Bivalirudin versus unfractionated heparin in patients with myocardial infarction undergoing percutaneous coronary intervention: A systematic review and meta-analysis of randomized controlled trials.

Al-Abdouh A et al. · Cardiovascular revascularization medicine : including molecular interventions

Added to ASH registry: 2026-05-28

Cancer-associated thrombosis: enhanced awareness and pathophysiologic complexity.

Falanga et al. · Journal of thrombosis and haemostasis : JTH

Added to ASH registry: 2026-05-28

Catheter-Directed Thrombolysis for Deep Vein Thrombosis: Serving at Break Point.

Barnes GD et al. · Thrombosis and haemostasis

Added to ASH registry: 2026-05-28

Catheter-Directed Thrombolysis Protocols for Deep Venous Thrombosis of the Lower Extremities-A Systematic Review and Meta-analysis.

Duarte-Gamas L et al. · Thrombosis and haemostasis

Added to ASH registry: 2026-05-28

Chromogenic and Clot-Based Bivalirudin Assays for Monitoring Anticoagulation

Raghavendran et al. · The journal of applied laboratory medicine

Added to ASH registry: 2026-05-28

Clinical Outcomes of Anticoagulated Patients With Atrial Fibrillation After Falls or Head Injury: Insights From RE-LY.

Caldeira et al. · Stroke

Added to ASH registry: 2026-05-28

Comparative Efficacy and Safety of Thrombolytic Agents for Pulmonary Embolism: A Bayesian Network Meta-Analysis.

Li H et al. · Pharmacology

Added to ASH registry: 2026-05-28

Comparison of Bivalirudin Versus Heparin for Anticoagulation During Extracorporeal Membrane Oxygenation

Hasegawa et al. · ASAIO journal (American Society for Artificial Internal Organs : 1992)

Added to ASH registry: 2026-05-28

Concomitant Left Atrial Appendage Occlusion and Transcatheter Aortic Valve Replacement Among Patients With Atrial Fibrillation.

Kapadia SR et al. · Circulation

Added to ASH registry: 2026-05-28

Correlation between partial thromboplastin time and thromboelastography in adult critically ill patients requiring bivalirudin for extracorporeal membrane oxygenation

Buckley et al. · Pharmacotherapy

Added to ASH registry: 2026-05-28

Cost-effectiveness of bivalirudin in pediatric ventricular assist devices

Burstein et al. · The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation

Added to ASH registry: 2026-05-28

Coumarins as factor XIIa inhibitors: Potency and selectivity improvements using a fragment-based strategy

Davoine et al. · European journal of medicinal chemistry

Added to ASH registry: 2026-05-28

Cryo-EM structure of coagulation factor V short.

Mohammed et al. · Blood

Added to ASH registry: 2026-05-28

Dabigatran etexilate is efficacious in consumptive coagulopathy and pain associated with venous malformations

Liu et al. · Journal of vascular surgery. Venous and lymphatic disorders

Added to ASH registry: 2026-05-28

Dabigatran-reversal failure using standard dose of idarucizumab: a systematic review and meta-analysis of cases

Melicine et al. · Research and practice in thrombosis and haemostasis

Added to ASH registry: 2026-05-28

Design and Preclinical Characterization Program toward Asundexian (BAY 2433334), an Oral Factor XIa Inhibitor for the Prevention and Treatment of Thromboembolic Disorders

Roehrig et al. · Journal of medicinal chemistry

Added to ASH registry: 2026-05-28

Determination of the Potential Clinical Benefits of Small Molecule Factor XIa Inhibitors in Arterial Thrombosis

Wichaiyo et al. · ACS pharmacology & translational science

Added to ASH registry: 2026-05-28

Development of new anticoagulant in 2023: Prime time for anti-factor XI and XIa inhibitors

Bentounes et al. · Journal de medecine vasculaire

Added to ASH registry: 2026-05-28

Diagnosis and laboratory monitoring of acquired hemophilia A.

Platton et al. · Hematology. American Society of Hematology. Education Program

Added to ASH registry: 2026-05-28

Direct Oral Anticoagulants for Stroke Prevention in Patients With Device-Detected Atrial Fibrillation: A Study-Level Meta-Analysis of the NOAH-AFNET 6 and ARTESiA Trials.

McIntyre et al. · Circulation

Added to ASH registry: 2026-05-28

Discovery and development of Factor Xa inhibitors (2015-2022)

Zheng et al. · Frontiers in pharmacology

Added to ASH registry: 2026-05-28

Early high-dose intravenous immunoglobulin for refractory heparin-induced thrombocytopenia with stroke: Two case reports

Makita et al. · Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association

Added to ASH registry: 2026-05-28

Edoxaban for 12 Months Versus 3 Months in Patients With Cancer With Isolated Distal Deep Vein Thrombosis (ONCO DVT Study): An Open-Label, Multicenter, Randomized Clinical Trial

Yamashita et al. · Circulation

Added to ASH registry: 2026-05-28

Edoxaban Versus Low-Molecular-Weight Heparin in Hospitalized COVID-19 Patients With Atrial Fibrillation

Olivera et al. · Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis

Added to ASH registry: 2026-05-28

Effect of Anticoagulant Versus Non-Anticoagulant Therapy on Mortality of Sepsis-Induced Disseminated Intravascular Coagulation: A Systematic Review and Meta-Analysis.

Qi et al. · Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis

Added to ASH registry: 2026-05-28

Effect of PCC on Thrombin Generation among Patients on Factor Xa Inhibitors with Major Bleeding or Needing Urgent Surgery (GAUGE): Design and Rationale

Shaw et al. · TH open : companion journal to thrombosis and haemostasis

Added to ASH registry: 2026-05-28

Effectiveness and safety of catheter-directed thrombolysis in conjunction with percutaneous mechanical thrombectomy for acute iliofemoral deep vein thrombosis: A meta-analysis.

Li W et al. · Journal of vascular surgery. Venous and lymphatic disorders

Added to ASH registry: 2026-05-28

Effectiveness and Safety of Dabigatran Reversal with Idarucizumab in the Taiwanese Population: A Comparison Based on Eligibility for Inclusion in Clinical Trials.

Dai et al. · Medicina (Kaunas, Lithuania)

Added to ASH registry: 2026-05-28

Efficacy and Safety of Apixaban versus Dalteparin as a Treatment for Cancer-Associated Venous Thromboembolism: A Systematic Review and Meta-Analysis

Arce-Huamani et al. · Medicina (Kaunas, Lithuania)

Added to ASH registry: 2026-05-28

Efficacy and safety of edoxaban in patients early after surgical bioprosthetic valve implantation or valve repair: A randomized clinical trial

Shim et al. · The Journal of thoracic and cardiovascular surgery

Added to ASH registry: 2026-05-28

Efficacy and safety of garadacimab, a factor XIIa inhibitor for hereditary angioedema prevention (VANGUARD): a global, multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Craig et al. · Lancet (London, England)

Added to ASH registry: 2026-05-28

Evaluation and Management of Chronic Thromboembolic Pulmonary Hypertension.

Yang J et al. · Chest

Added to ASH registry: 2026-05-28

Evaluation of mechanical thrombectomy in acute ischemic stroke related to a distal arterial occlusion: A randomized controlled trial.

Clarençon F et al. · International journal of stroke : official journal of the International Stroke Society

Added to ASH registry: 2026-05-28

Experimentally Validated Novel Factor XIIa Inhibitors Identified by Docking and Quantum Chemical Post-processing

Ilin et al. · Molecular informatics

Added to ASH registry: 2026-05-28

Factor XI inhibitors for the prevention of cardiovascular disease: A new therapeutic approach on the horizon?

Santagata et al. · Blood reviews

Added to ASH registry: 2026-05-28

Factor XI Inhibitors in Early Clinical Trials: A Meta-analysis

Galli et al. · Thrombosis and haemostasis

Added to ASH registry: 2026-05-28

Factor XI Inhibitors: Potential Role in End-Stage Kidney Disease

Ades et al. · Seminars in nephrology

Added to ASH registry: 2026-05-28

Factor XIa Inhibitors as a Novel Anticoagulation Target: Recent Clinical Research Advances

Xia et al. · Pharmaceuticals (Basel, Switzerland)

Added to ASH registry: 2026-05-28

Factor XIa Inhibitors in Anticoagulation Therapy: Recent Advances and Perspectives

Xie et al. · Journal of medicinal chemistry

Added to ASH registry: 2026-05-28

Final Study Report of Andexanet Alfa for Major Bleeding With Factor Xa Inhibitors.

Milling et al. · Circulation

Added to ASH registry: 2026-05-28

Heparin-induced thrombocytopenia after switching from unfractionated heparin to low-molecular-weight heparin: A case report and literature review

Zhang et al. · Clinical nephrology

Added to ASH registry: 2026-05-28

Idarucizumab for dabigatran reversal: A systematic review and meta-analysis of indications and outcomes.

van et al. · Thrombosis research

Added to ASH registry: 2026-05-28

Idarucizumab for Emergency Reversal of the Anticoagulant Effects of Dabigatran: Final Results of a Japanese Postmarketing Surveillance Study

Yasaka et al. · Cardiology and therapy

Added to ASH registry: 2026-05-28

Identification and characterization of a novel 6'-N-aminoglycoside acetyltransferase AAC(6')-Va from a clinical isolate of.

Zhang G et al. · Frontiers in microbiology

Added to ASH registry: 2026-05-28

In Silico and In Vitro Evaluation of Some Amidine Derivatives as Hit Compounds towards Development of Inhibitors against Coronavirus Diseases.

Hassan AHE et al. · Viruses

Added to ASH registry: 2026-05-28

In vitro Effect of Dalteparin and Argatroban on Hemostasis in Critically Ill Sepsis Patients with New-Onset Thrombocytopenia

Nygaard et al. · TH open : companion journal to thrombosis and haemostasis

Added to ASH registry: 2026-05-28

Incidence and risk factors for venous thromboembolism in the Cancer-VTE Registry pancreatic cancer subcohort.

Okusaka et al. · Journal of gastroenterology

Added to ASH registry: 2026-05-28

Incidence of Venous Thromboembolism Among Commonly Prescribed Second-Generation Antipsychotics.

Paulmann et al. · Journal of pharmacy practice

Added to ASH registry: 2026-05-28

Incidence of venous thromboembolism following adrenalectomy: A CESQIP analysis.

Sada et al. · American journal of surgery

Added to ASH registry: 2026-05-28

Interactions Between Direct Oral Anticoagulants (DOACs) and Antiseizure Medications: Potential Implications on DOAC Treatment.

Goldstein R et al. · CNS drugs

Added to ASH registry: 2026-05-28

Investigating Betrixaban Maleate drug degradation profiles, isolation and characterization of unknown degradation products by mass-triggered preparative HPLC, HRMS, and NMR

Surukonti et al. · Journal of pharmaceutical and biomedical analysis

Added to ASH registry: 2026-05-28

Laboratory-guided repeat dosing of idarucizumab for dabigatran reversal

Jones et al. · Clinical toxicology (Philadelphia, Pa.)

Added to ASH registry: 2026-05-28

Long-term survival in venous thromboembolic disease: rivaroxaban vs. warfarin - propensity score matching study

Ramos-Isaza et al. · BMC pharmacology & toxicology

Added to ASH registry: 2026-05-28

Management of splanchnic vein thrombosis.

Elkrief et al. · JHEP reports : innovation in hepatology

Added to ASH registry: 2026-05-28

Mechanical thrombectomy for acute ischemic stroke with large vessel occlusion in pregnancy with mechanical heart valves： A case report.

Zhang et al. · Heliyon

Added to ASH registry: 2026-05-28

Mechanisms and management of the coagulopathy of trauma and sepsis: trauma-induced coagulopathy, sepsis-induced coagulopathy, and disseminated intravascular coagulation.

Iba et al. · Journal of thrombosis and haemostasis : JTH

Added to ASH registry: 2026-05-28

Membrane oxygenator longevity was higher in argatroban-treated patients undergoing vvECMO

Menninger et al. · European journal of clinical investigation

Added to ASH registry: 2026-05-28

Microwave assisted synthesis of fluorescent hetero atom doped carbon dots for determination of betrixaban with greenness evaluation

El-Semary et al. · RSC advances

Added to ASH registry: 2026-05-28

Myeloproliferative neoplasms and splanchnic vein thrombosis: Contemporary diagnostic and therapeutic strategies.

Kiladjian et al. · American journal of hematology

Added to ASH registry: 2026-05-28

New pharmacotherapeutic options for oral anticoagulant treatment in atrial fibrillation patients aged 65 and older: factor XIa inhibitors and beyond

Santostasi et al. · Expert opinion on pharmacotherapy

Added to ASH registry: 2026-05-28

New Therapeutic Targets for the Prevention and Treatment of Venous Thromboembolism With a Focus on Factor XI Inhibitors

Chan et al. · Arteriosclerosis, thrombosis, and vascular biology

Added to ASH registry: 2026-05-28

News at XI: moving beyond factor Xa inhibitors

Fredenburgh et al. · Journal of thrombosis and haemostasis : JTH

Added to ASH registry: 2026-05-28

Novel Monitoring and Dose Adjustment of Argatroban, a Direct Thrombin Inhibitor, to Maintain Therapeutic Anticoagulation in a Patient With Antiphospholipid Antibody Syndrome, Heparin-Induced Thrombocytopenia, and COVID-19 Pneumonia

Ryan CE et al. · Critical care explorations

Added to ASH registry: 2026-05-28

OKL-1111, A modified cyclodextrin as a potential universal reversal agent for anticoagulants

Meijers et al. · Thrombosis research

Added to ASH registry: 2026-05-28

One case of recurrent ST-segment elevation myocardial infarction in a patient with antiphospholipid syndrome complicated with severe thrombocytopenia within a short period of time: A case report.

Qiu Z et al. · Medicine

Added to ASH registry: 2026-05-28

Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of deep vein thrombosis

Wang et al. · The Cochrane database of systematic reviews

Added to ASH registry: 2026-05-28

Oral factor Xa inhibitor underutilization following lower extremity peripheral vascular intervention

Bhuta et al. · Journal of vascular surgery

Added to ASH registry: 2026-05-28

Oral FXIIa inhibitor KV998086 suppresses FXIIa and single chain FXII mediated kallikrein kinin system activation

Clermont et al. · Frontiers in pharmacology

Added to ASH registry: 2026-05-28

Outcome after intracranial hemorrhage under dabigatran and reversal with idarucizumab versus under vitamin-K-antagonists - the RIC-ICH study.

Kuklik et al. · Frontiers in neurology

Added to ASH registry: 2026-05-28

Percutaneous Management of High-Risk Pulmonary Embolism.

Carroll et al. · Circulation. Cardiovascular interventions

Added to ASH registry: 2026-05-28

Perioperative Myocardial Infarction Following Dabigatran Reversal With Idarucizumab in a Patient Undergoing Orthotopic Liver Transplantation

Barroso et al. · Cureus

Added to ASH registry: 2026-05-28

Pharmacokinetic and Pharmacodynamic Interactions Between Henagliflozin, a Novel Selective SGLT-2 Inhibitor, and Warfarin in Healthy Chinese Subjects

He et al. · Clinical therapeutics

Added to ASH registry: 2026-05-28

Pharmacology and Clinical Development of Factor XI Inhibitors

Greco et al. · Circulation

Added to ASH registry: 2026-05-28

Platelet function testing and clinical outcomes in peripheral arterial disease: Systematic review and narrative synthesis.

Kankaria et al. · Journal of vascular surgery

Added to ASH registry: 2026-05-28

Prolonged infusion of bivalirudin after elective percutaneous coronary intervention protects against procedural myocardial injury (a COBER study)-a randomized trial.

Wu et al. · Scientific reports

Added to ASH registry: 2026-05-28

Prospection of Peptide Inhibitors of Thrombin from Diverse Origins Using a Machine Learning Pipeline

Balakrishnan N et al. · Bioengineering (Basel, Switzerland)

Added to ASH registry: 2026-05-28

Real world utilization of Andexanet alfa in the management of oral factor Xa inhibitor-associated gastrointestinal bleeding

Brown et al. · The American journal of emergency medicine

Added to ASH registry: 2026-05-28

Real-world clinical outcomes among US Veterans with oral factor xa inhibitor-related major bleeding treated with andexanet alfa or 4-factor prothrombin complex concentrate

Sutton et al. · Journal of thrombosis and thrombolysis

Added to ASH registry: 2026-05-28

Reduced dose direct oral anticoagulants compared with warfarin with high time in therapeutic range in nonvalvular atrial fibrillation

Jansson et al. · Journal of thrombosis and thrombolysis

Added to ASH registry: 2026-05-28

Removing direct oral factor Xa inhibitor interferences from routine and specialised coagulation assays using a raw activated charcoal product

Buckley et al. · Clinica chimica acta; international journal of clinical chemistry

Added to ASH registry: 2026-05-28

Retrospective Analysis of the Real-World Utilization of 4-Factor Prothrombin Complex Concentrate and Plasma in Oral Anticoagulant-Associated Bleeding in US Hospitals.

Refaai et al. · Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis

Added to ASH registry: 2026-05-28

Reversal agents for current and forthcoming direct oral anticoagulants

van et al. · European heart journal

Added to ASH registry: 2026-05-28

Risk stratification of acute pulmonary embolism.

de Wit et al. · Journal of thrombosis and haemostasis : JTH

Added to ASH registry: 2026-05-28

Role of Infrared Thermography in Planning and Monitoring of Head and Neck Microvascular Flap Reconstruction

Chava SK et al. · Plastic and reconstructive surgery. Global open

Added to ASH registry: 2026-05-28

Safety and efficacy of apixaban versus low-molecular weight heparin or vitamin-K antagonists for venous thromboembolism treatment in patients with severe renal failure: A systematic review and meta-analysis

Almajdi et al. · Thrombosis research

Added to ASH registry: 2026-05-28

Sepsis-Induced Coagulopathy and Disseminated Intravascular Coagulation: What We Need to Know and How to Manage for Prolonged Casualty Care.

Nam et al. · Journal of special operations medicine : a peer reviewed journal for SOF medical professionals

Added to ASH registry: 2026-05-28

Sepsis-induced Coagulopathy Subphenotype Identification by Latent Class Analysis.

Cai et al. · Balkan medical journal

Added to ASH registry: 2026-05-28

Stability of Rivaroxaban and Apixaban Anti-Xa Activities in Whole Blood Samples: A French Bicentric Study

Raynor et al. · Thrombosis and haemostasis

Added to ASH registry: 2026-05-28

Standard operating procedure for idarucizumab reversal of dabigatran anticoagulation in ischemic and hemorrhagic stroke.

Frol et al. · Journal of thrombosis and thrombolysis

Added to ASH registry: 2026-05-28

Study of Rivaroxaban for Cerebral Venous Thrombosis: A Randomized Controlled Feasibility Trial Comparing Anticoagulation With Rivaroxaban to Standard-of-Care in Symptomatic Cerebral Venous Thrombosis

Field et al. · Stroke

Added to ASH registry: 2026-05-28

Tenecteplase versus alteplase in acute ischaemic cerebrovascular events (TRACE-2): a phase 3, multicentre, open-label, randomised controlled, non-inferiority trial.

Wang Y et al. · Lancet (London, England)

Added to ASH registry: 2026-05-28

The effects of coagulation factors on the risk of endometriosis: a Mendelian randomization study.

Li et al. · BMC medicine

Added to ASH registry: 2026-05-28

The pathophysiology, diagnosis, and management of sepsis-associated disseminated intravascular coagulation.

Iba et al. · Journal of intensive care

Added to ASH registry: 2026-05-28

The Safety, Pharmacokinetics, and Pharmacodynamics of SHR2285, an Oral Small Molecule Factor XIa Inhibitor, in Healthy Chinese Volunteers

Xu et al. · Clinical drug investigation

Added to ASH registry: 2026-05-28

The Utility of Smartphone-Based Thermal Imaging in the Management and Monitoring of Microvascular Flap Procedures: A Systematic Review and Meta-Analysis

Hudson T et al. · Annals of plastic surgery

Added to ASH registry: 2026-05-28

Thrombolysis after dabigatran reversal: A nation-wide Italian multicentre study, systematic review and meta-analysis

Romoli et al. · European stroke journal

Added to ASH registry: 2026-05-28

Thrombolysis for acute ischaemic stroke: current status and future perspectives.

Tsivgoulis G et al. · The Lancet. Neurology

Added to ASH registry: 2026-05-28

ThromboprophylaXIs with Factor XI/XIa inhibitors for venous thromboembolism

PorresAguilar et al. · Jornal vascular brasileiro

Added to ASH registry: 2026-05-28

Towards understanding the effect of fibrinogen interactions on fibrin gel structure.

Nelson et al. · Physical review. E

Added to ASH registry: 2026-05-28

Treatment of Factor-Xa Inhibitor-associated Bleeding with Andexanet Alfa or 4 Factor PCC: A Multicenter Feasibility Retrospective Study

Singer et al. · The western journal of emergency medicine

Added to ASH registry: 2026-05-28

Updated guidance for efficacy and safety outcomes for clinical trials in venous thromboembolism in children: communication from the ISTH SSC Subcommittee on Pediatric and Neonatal Thrombosis and Hemostasis.

Whitworth H et al. · Journal of thrombosis and haemostasis : JTH

Added to ASH registry: 2026-05-28

Venous and arterial thromboembolism after colorectal cancer in the Netherlands: Incidence, predictors, and prognosis.

Anijs et al. · Thrombosis research

Added to ASH registry: 2026-05-28

Venous Thromboembolism Prophylaxis in Major Orthopedic Surgeries and Factor XIa Inhibitors

Jones et al. · Medical sciences (Basel, Switzerland)

Added to ASH registry: 2026-05-28

Venous thromboembolism: Exploring incidence and utility of screening in spinal cord injury.

Draganich et al. · The journal of spinal cord medicine

Added to ASH registry: 2026-05-28

Viscoelastic Testing Methods.

Carll · Advances in clinical chemistry

Added to ASH registry: 2026-05-28

Von Willebrand Disease, Hemophilia, and Other Inherited Bleeding Disorders in Pregnancy.

Pacheco LD et al. · Obstetrics and gynecology

Added to ASH registry: 2026-05-28

Warfarin vs doac: Comparative outcomes of mechanical thrombectomy for acute ischemic stroke in atrial fibrillation patients.

Ramazanoglu et al. · Clinical neurology and neurosurgery

Added to ASH registry: 2026-05-28

When and How to Use Reversal Agents for Direct Oral Anticoagulants?.

Gómez-Outes et al. · Current cardiology reports

Added to ASH registry: 2026-05-28

Alternative Non-Drug Treatment Options of the Most Neglected Parasitic Disease Cutaneous Leishmaniasis: A Narrative Review

Orabi MAA et al. · Tropical medicine and infectious disease

Added to ASH registry: 2026-05-27

Anticoagulation with Intravenous Direct Thrombin Inhibitors in Pediatric Extracorporeal Membrane Oxygenation: A Systematic Review of the Literature

Kiskaddon AL et al. · Seminars in thrombosis and hemostasis

Added to ASH registry: 2026-05-27

Biomimetic platelet nanomotors for site-specific thrombolysis and ischemic injury alleviation

Chen YT et al. · ACS applied materials & interfaces

Added to ASH registry: 2026-05-27

Bivalirudin anticoagulation for cardiopulmonary bypass during cardiac surgery

Meshulami N et al. · Perfusion

Added to ASH registry: 2026-05-27

Bivalirudin for cardiopulmonary bypass in a patient with heparin allergy

Boysan E et al. · J Cardiothorac Surg

Added to ASH registry: 2026-05-27

Bivalirudin in acute coronary syndromes

Galli M et al. · Expert review of cardiovascular therapy